CLOUDERA, INC., 10-K filed on 3/25/2021
Annual Report
v3.21.1
Cover Page - USD ($)
$ in Billions
 12 Months Ended
Jan. 31, 2021
Feb. 28, 2021
Jul. 31, 2020
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 31, 2021    
Current Fiscal Year End Date --01-31    
Document Transition Report false    
Entity File Number 001-38069    
Entity Registrant Name CLOUDERA, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 26-2922329    
Entity Address, Address Line One 5470 Great America Parkway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95054    
City Area Code 650    
Local Phone Number 362-0488    
Title of 12(b) Security Common Stock, $0.00005 par value per share    
Trading Symbol CLDR    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 3.0
Entity Common Stock, Shares Outstanding (In shares)   291,399,179  
Documents Incorporated by Reference Information required in response to Part II and Part III of Form 10-K is hereby incorporated by reference to portions of the Registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held in 2021. The Proxy Statement will be filed by the Registrant with the Securities and Exchange Commission no later than 120 days after the end of the Registrant’s fiscal year ended January 31, 2021.    
Entity Central Index Key 0001535379    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Current Assets:    
Cash and cash equivalents $ 298,672 $ 107,638
Marketable securities 297,721 253,361
Accounts receivable, net 316,098 249,971
Deferred contract costs 53,048 54,776
Prepaid expenses and other current assets 32,382 42,155
Total current assets 997,921 707,901
Property and equipment, net 18,065 21,988
Marketable securities, non-current 173,281 122,193
Intangible assets, net 532,630 605,236
Goodwill 599,291 590,361
Deferred contract costs, non-current 31,170 35,260
Operating lease right-of-use assets 146,424 204,642
Other assets 9,819 12,209
TOTAL ASSETS 2,508,601 2,299,790
Current Liabilities:    
Accounts payable 2,713 3,858
Accrued compensation 56,643 61,826
Other accrued liabilities 30,196 22,297
Operating lease liabilities 19,574 19,181
Contract liabilities 553,983 472,786
Total current liabilities 663,109 579,948
Long-term debt 487,089 0
Operating lease liabilities, non-current 169,296 192,324
Contract liabilities, non-current 54,414 81,926
Other accrued liabilities, non-current 6,763 7,223
TOTAL LIABILITIES 1,380,671 861,421
Commitments and contingencies
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.00005 par value; 20,000,000 shares authorized, no shares issued and outstanding at January 31, 2021 and 2020 0 0
Common stock $0.00005 par value; 1,200,000,000 shares authorized at January 31, 2021 and 2020; 291,220,735 and 295,167,761 shares issued and outstanding at January 31, 2021 and 2020, respectively 15 15
Additional paid-in capital 2,776,690 2,923,905
Accumulated other comprehensive income 580 273
Accumulated deficit (1,649,355) (1,485,824)
TOTAL STOCKHOLDERS’ EQUITY 1,127,930 1,438,369
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 2,508,601 $ 2,299,790
v3.21.1
Consolidated Balance Sheets - Parenthetical - $ / shares
Jan. 31, 2021
Jan. 31, 2020
Statement of Financial Position [Abstract]    
Preferred stock par value (in dollars per share) $ 0.00005 $ 0.00005
Preferred stock authorized (in shares) 20,000,000 20,000,000
Preferred stock issued (in shares) 0 0
Preferred stock outstanding (in shares) 0 0
Common stock par value (in dollars per share) $ 0.00005 $ 0.00005
Common stock authorized (in shares) 1,200,000,000 1,200,000,000
Common stock issued (in shares) 291,220,735 295,167,761
Common stock outstanding (in shares) 291,220,735 295,167,761
v3.21.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Revenue:      
Revenue from Contract with Customer, Excluding Assessed Tax $ 869,258 $ 794,191 $ 479,941
Cost of revenue:      
Total cost of revenue [1],[2] 189,188 232,502 136,114
Gross profit 680,070 561,689 343,827
Operating expenses:      
Research and development [1],[2] 244,507 263,566 173,814
Sales and marketing [1],[2] 420,501 467,541 253,164
General and administrative [1],[2],[3] 171,327 170,336 110,613
Total operating expenses [1],[2] 836,335 901,443 537,591
Loss from operations (156,265) (339,754) (193,764)
Interest income, net 3,994 11,687 9,011
Other income (expense), net (3,117) 185 (2,478)
Loss before provision for income taxes (155,388) (327,882) (187,231)
Provision for income taxes (7,346) (8,700) (5,418)
Net loss $ (162,734) $ (336,582) $ (192,649)
Net loss per share, basic and diluted (in dollars per share) $ (0.54) $ (1.20) $ (1.21)
Weighted-average shares used in computing net loss per share, basic and diluted (in shares) 302,522 280,772 159,816
Subscription      
Revenue:      
Revenue from Contract with Customer, Excluding Assessed Tax $ 782,769 $ 667,826 $ 406,333
Cost of revenue:      
Total cost of revenue [1],[2] 107,834 117,739 63,329
Services      
Revenue:      
Revenue from Contract with Customer, Excluding Assessed Tax 86,489 126,365 73,608
Cost of revenue:      
Total cost of revenue [1],[2] $ 81,354 $ 114,763 $ 72,785
[1] Amounts include amortization of acquired intangible assets as follows (in thousands):
Years Ended January 31,
202120202019
Cost of revenue - subscription$11,880 $11,213 $3,251 
Sales and marketing 66,426 68,811 5,878 
[2] Amounts include stock-based compensation expense as follows (in thousands):
Years Ended January 31,
202120202019
Cost of revenue – subscription $15,123 $16,599 $9,959 
Cost of revenue – services 11,909 17,609 11,492 
Research and development 72,087 75,554 41,430 
Sales and marketing 55,173 63,360 27,918 
General and administrative 34,643 47,232 26,566 
[3] Amounts include the impairment of real estate lease related right-of-use assets and other long-lived assets of $35.8 million for the year ended January 31, 2021.
v3.21.1
Consolidated Statements of Operations - Parenthetical - USD ($)
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Amortization expense of intangible assets $ 78,300,000 $ 80,000,000.0 $ 9,100,000
Impairment of real estate lease related assets 35,828,000 0 0
Subscription      
Stock-based compensation expense 15,123,000 16,599,000 9,959,000
Amortization expense of intangible assets 11,880,000 11,213,000 3,251,000
Services      
Stock-based compensation expense 11,909,000 17,609,000 11,492,000
Research and development      
Stock-based compensation expense 72,087,000 75,554,000 41,430,000
Sales and marketing      
Stock-based compensation expense 55,173,000 63,360,000 27,918,000
Amortization expense of intangible assets 66,426,000 68,811,000 5,878,000
General and administrative      
Stock-based compensation expense $ 34,643,000 $ 47,232,000 $ 26,566,000
v3.21.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Statement of Comprehensive Income [Abstract]      
Net loss $ (162,734) $ (336,582) $ (192,649)
Other comprehensive income, net of tax:      
Foreign currency translation gain (loss) 32 (935) 34
Unrealized gain on investments 275 1,250 756
Total other comprehensive income, net of tax 307 315 790
Comprehensive loss $ (162,427) $ (336,267) $ (191,859)
v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Outstanding beginning of period (in shares) at Jan. 31, 2018     145,327        
Beginning balance at Jan. 31, 2018 $ 428,174   $ 7 $ 1,385,592 $ (832) $ (956,593)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued under employee stock plans (in shares)     3,827        
Shares issued under employee stock plans 22,179     22,179      
Shares issued from restricted stock units vesting (in shares)     9,080        
Stock-based compensation expense 117,365     117,365      
Shares issued in a business combination (in shares)     111,305        
Shares issued in a business combination 1,202,428   $ 6 1,202,422      
Shares withheld related to net settlement of equity awards (in shares)     (720)        
Shares withheld related to net settlement of equity awards (16,218)     (16,218)      
Unrealized gain on investments 756       756    
Foreign currency translation gain (loss) 34       34    
Net loss (192,649)         (192,649)  
Outstanding end of period (in shares) at Jan. 31, 2019     268,819        
Ending balance at Jan. 31, 2019 $ 1,562,069   $ 13 2,711,340 (42) (1,149,242)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Shares issued under employee stock plans (in shares)     4,396        
Shares issued under employee stock plans $ 12,676     12,676      
Shares issued from restricted stock units vesting (in shares)     23,273        
Shares issued from restricted stock units vesting 2   $ 2 0      
Shares issued under employee stock purchase plan (in shares)     2,498        
Shares issued under employee stock purchase plan 12,156     12,156      
Stock-based compensation expense 220,354     220,354      
Shares withheld related to net settlement of equity awards (in shares)     (3,818)        
Shares withheld related to net settlement of equity awards (32,621)     (32,621)      
Unrealized gain on investments 1,250       1,250    
Foreign currency translation gain (loss) (935)       (935)    
Net loss (336,582)         (336,582)  
Outstanding end of period (in shares) at Jan. 31, 2020     295,168        
Ending balance at Jan. 31, 2020 1,438,369 $ (797) $ 15 2,923,905 273 (1,485,824) $ (797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued under employee stock plans (in shares)     9,197        
Shares issued under employee stock plans 35,770     35,770      
Shares issued from restricted stock units vesting (in shares)     20,059        
Shares issued from restricted stock units vesting 0   $ 1 (1)      
Shares issued under employee stock purchase plan (in shares)     1,513        
Shares issued under employee stock purchase plan 15,394     15,394      
Repurchases of common stock (in shares)     (30,011)        
Repurchases of common stock (340,066)   $ (1) (340,065)      
Stock-based compensation expense 188,935     188,935      
Shares withheld related to net settlement of equity awards (in shares)     (4,705)        
Shares withheld related to net settlement of equity awards (47,248)     (47,248)      
Unrealized gain on investments 275       275    
Foreign currency translation gain (loss) 32       32    
Net loss (162,734)         (162,734)  
Outstanding end of period (in shares) at Jan. 31, 2021     291,221        
Ending balance at Jan. 31, 2021 $ 1,127,930   $ 15 $ 2,776,690 $ 580 $ (1,649,355)  
v3.21.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (162,734,000) $ (336,582,000) $ (192,649,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 89,393,000 92,156,000 17,428,000
Non-cash lease expense 45,747,000 45,640,000 0
Impairment of real estate lease related assets 35,828,000 0 0
Stock-based compensation expense 188,935,000 220,354,000 117,365,000
Amortization of deferred contract costs 66,734,000 47,552,000 30,634,000
Other 9,395,000 (1,880,000) (1,431,000)
Changes in assets and liabilities:      
Accounts receivable (65,061,000) (8,956,000) 54,231,000
Prepaid expenses and other assets 12,151,000 (8,280,000) 14,606,000
Deferred contract costs (60,916,000) (68,575,000) (39,665,000)
Accounts payable (2,816,000) (4,089,000) 3,795,000
Accrued compensation (6,140,000) 5,570,000 (17,962,000)
Other accrued liabilities 1,187,000 109,000 5,413,000
Operating lease liabilities (46,022,000) (51,059,000) 0
Other contract liabilities 50,141,000 31,214,000 42,508,000
Net cash provided by (used in) operating activities 155,822,000 (36,826,000) 34,273,000
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of marketable securities (472,715,000) (494,252,000) (462,737,000)
Proceeds from sale of marketable securities 120,329,000 86,739,000 56,702,000
Maturities of marketable securities 254,763,000 413,557,000 435,478,000
Cash used in business combinations, net of cash acquired (12,358,000) (4,500,000)  
Cash acquired in a business combination     42,557,000
Capital expenditures (10,053,000) (7,203,000) (10,041,000)
Net cash (used in) provided by investing activities (120,034,000) (5,659,000) 61,959,000
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from debt, net of issuance costs 490,546,000 0 0
Repurchases of common stock (340,065,000) 0 0
Taxes paid related to net share settlement of equity awards (47,248,000) (32,621,000) (16,218,000)
Proceeds from employee stock plans 51,064,000 25,664,000 21,844,000
Net cash provided by (used in) financing activities 154,297,000 (6,957,000) 5,626,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash 949,000 (1,607,000) (1,118,000)
Net increase (decrease) in cash, cash equivalents and restricted cash 191,034,000 (51,049,000) 100,740,000
Cash, cash equivalents and restricted cash — Beginning of period 110,990,000 162,039,000 61,299,000
Cash, cash equivalents and restricted cash — End of period 302,024,000 110,990,000 162,039,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION      
Cash paid for income taxes 9,562,000 7,760,000 4,775,000
Purchases of property and equipment, accrued but not yet paid 15,000 45,000 208,000
Fair value of common stock issued as consideration for a business combination 0 0 1,154,230,000
Fair value of equity awards assumed in a business combination 0 0 48,197,000
Right-of-use assets obtained in exchange for new operating lease liabilities 9,412,000 7,392,000 0
Reconciliation of cash, cash equivalents and restricted cash as shown in the statement of cash flows      
Total cash, cash equivalents and restricted cash $ 302,024,000 $ 162,039,000 $ 61,299,000
v3.21.1
Summary of Business and Significant Accounting Policies
 12 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]  
Summary of Business and Significant Accounting Policies Summary of Business and Significant Accounting Policies
Description of Business
Cloudera, Inc. was incorporated in the state of Delaware on June 27, 2008 and is headquartered in Santa Clara, California. Cloudera is an enterprise data cloud company. We sell software subscriptions and public cloud services for the Cloudera Data Platform (CDP) solution-set and software subscriptions for our traditional on-premises data platforms. Subscriptions include software access rights and technical support. We also provide professional services for the implementation and use of our software subscriptions, machine learning expertise and consultation, training and education services. Our offerings are based predominantly on open source software, utilizing data stored natively in public cloud object stores as well as in various open source data stores. Unless the context requires otherwise, the words “we,” “us,” “our” and “Cloudera” refer to Cloudera, Inc. and its subsidiaries taken as a whole.
In January 2019, we completed a merger with Hortonworks, Inc, pursuant to which Hortonworks, Inc. became a subsidiary of Cloudera.
Basis of Consolidation
The consolidated financial statements include the accounts of Cloudera, Inc. and its wholly owned subsidiaries which are located in various countries, including the United States, Australia, China, India, Germany, Ireland, The Netherlands, Singapore, Hungary and the United Kingdom. All intercompany balances and transactions have been eliminated upon consolidation. The financial statements are prepared in accordance with accounting principles generally accepted in the United States (GAAP).
Fiscal Year
Our fiscal year ends on January 31. References to fiscal 2021, for example, refers to the fiscal year ending January 31, 2021.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant items subject to such estimates include the useful lives of property and equipment and intangible assets, allowance for credit losses, stock-based compensation expense, bonus attainment, self-insurance costs incurred, the fair value and useful lives of tangible and intangible assets acquired and liabilities assumed resulting from business combinations, the evaluation for impairment of goodwill, intangible assets and other long-lived assets including operating lease right-of-use assets, the estimated period of benefit for deferred contract costs, estimates related to our revenue recognition such as, the assessment of elements in a multi-element arrangement and the value assigned to each element, contingencies, and the incremental borrowing rate used in discounting our lease liabilities. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.
Reclassifications
In the fourth quarter of fiscal 2021, we combined deferred revenue and other contract liabilities, both current and non-current, into contract liabilities current and non-current for all periods presented on our Consolidated Balance Sheets. All contract liabilities represent an obligation to transfer product offerings for which we have received consideration, or for which an amount of consideration is due from the customer (e.g., subscription arrangements where consideration is paid annually in advance).
Certain other immaterial prior year amounts have been reclassified to conform to current year presentation in the Balance Sheets, Consolidated Statements of Cash Flows and Notes to Consolidated Financial Statements.
Segments
We operate as two operating segments – subscription and services. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is our chief executive officer, in deciding how to allocate resources and assess performance.
Foreign Currency Translation
The functional currency of our foreign subsidiaries is generally the local currency. The gains and losses resulting from translating our foreign subsidiaries’ financial statements into U.S. dollars have been reported in accumulated other comprehensive income on the consolidated balance sheet. Assets and liabilities are translated at exchange rates in effect at the balance sheet date. Equity is translated at the historical rates from the original transaction period. Revenue and expenses are translated at average exchange rates in effect during the period. Foreign currency transaction gains and losses are included in other income (expense), net on the statement of operations.
Cash, Cash Equivalents and Restricted Cash
Cash equivalents consist of short-term, highly liquid investments with original maturities of three months or less from the date of purchase. Restricted cash represents cash on deposit with financial institutions in support of letters of credit outstanding in favor of certain landlords for office space.
Marketable Securities
We have investments in various marketable securities which are classified as available for sale. We determine the appropriate classification of marketable securities at the time of purchase and reevaluate such determination at each balance sheet date. The investments are adjusted for amortization of premiums and discounts to maturity and such amortization is included in interest income, net on the statement of operations. Changes in market value considered to be temporary are recorded as unrealized gains or losses in other comprehensive income (loss). Realized gains and losses and credit losses on available-for-sale securities are included in other income (expense), net on the statement of operations. The cost of securities sold is based on the specific-identification method.
Concentration of Credit Risk and Significant Customers
Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, restricted cash and accounts receivable. Our cash is deposited with high credit quality financial institutions. At times, such deposits may be in excess of the Federal Depository Insurance Corporation insured limits. We have not experienced any losses on these deposits.
As of January 31, 2021, one customer represented more than 10% of accounts receivable. No single customer represented more than 10% of accounts receivable as of January 31, 2020. For the years ended January 31, 2021, 2020 and 2019, no single customer accounted for 10% or more of revenue.
Accounts Receivable and Allowance for Credit Losses
Our trade receivables are recorded at the invoice amount, net of an allowance for credit losses, which is not material. The allowance for credit losses reflects our best estimate of probable losses inherent in the receivable portfolio determined based on various factors including historical experience, credit quality of the customer, current economic conditions and management’s expectations of future economic conditions. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. As of January 31, 2021 and 2020, allowance for credit losses was $2.7 million and $0.8 million, respectively. The movements in the allowance for credit losses were not significant for any of the periods presented.
The COVID-19 pandemic and the recent economic downturn prompted us to perform additional credit reviews of our existing customers. After performing our additional reviews, we determined that, while we may experience delays in our collections, the risk of credit loss on our trade receivables as of January 31, 2021 is not expected to materially differ from prior periods.
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization of property and equipment is calculated using a straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not extend the life or improve the asset are expensed when incurred.
The estimated useful lives of our assets are as follows:
Computer software
2 years
Computer equipment
2-3 years
Furniture and office equipment
3 years
Leasehold improvements Shorter of remaining lease term or estimated useful life
We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total of estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, would be assessed using discounted cash flows or other appropriate measures of fair value. There was no significant impairment of property and equipment during the years ended January 31, 2021, 2020 or 2019.
Leases
At the inception of a contract, we determine whether the contract is or contains a lease. All leases with a term greater than one year are recognized on the balance sheet as operating lease right-of-use (ROU) assets and lease liabilities. We have elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus will not have a lease liability or ROU asset recognized on the balance sheet.
ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease, which we do not include in our minimum lease terms unless the options are reasonably certain to be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.
We have lease agreements with lease and non-lease components which we have elected to account for as a single lease component. On the lease commencement date, we establish assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense.
Additionally, we have unoccupied leased office space that we have either subleased, plan to sublease or plan to abandon. Any impairments to the ROU asset, leasehold improvements or other assets as a result of an unoccupied leased office space are recognized as an operating expense in the period the sublease is executed or in the case of a planned sublease or planned abandonment, upon the day of cease-use and determination that the lease related ROU asset, leasehold improvements or other assets are impaired. Any sublease payments received in excess of the straight-line rent payments for the sublease are recorded as an offset to operating expenses and recognized over the sublease life.
In the fourth quarter of fiscal year 2021, we recorded an impairment charge of $34.0 million for ROU assets and $1.8 million for related leasehold improvements and IT infrastructure, primarily related to certain office locations we determined will no longer be used. The impairment was determined by comparing the fair value of the impacted ROU asset, lease hold improvements and IT infrastructure to the carrying value of the assets as of the impairment measurement date, as required under Accounting Standards Codification (ASC) Topic 360, Property, Plant, and Equipment. There were no impairment charges recognized during the years ended January 31, 2020 and 2019. See Note 10 for additional discussion related to these impairment charges.
Goodwill and Intangible Assets
Goodwill represents the excess of the fair value of purchase consideration in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized, but rather tested for impairment at least annually or more often if circumstances indicate that the carrying value may not be recoverable.
Intangible assets are amortized over their useful lives. Each period we evaluate the estimated remaining useful life of our intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.
We evaluate the recoverability of our long-lived assets, including intangible assets, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, then the carrying amount of such assets is reduced to fair value.
There were no impairments of goodwill or intangible assets during the years ended January 31, 2021, 2020 or 2019.
Derivative Contracts
We use derivative financial instruments as a part of our strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These derivative contracts consist of foreign currency forward contracts and are not designated as hedging instruments under the applicable accounting guidance. Accordingly, they are carried at fair value as either assets or liabilities on our consolidated balance sheets. The changes in the fair value are included in other income (expense), net within our consolidated statements of operations and are intended to offset the foreign currency gains or losses associated with the underlying monetary assets and liabilities.
Business Combinations
We use our best estimates and assumptions to assign fair value to tangible and intangible assets acquired and liabilities assumed at the acquisition or merger date. Such estimates are inherently uncertain and subject to refinement. We continue to collect information and reevaluate these estimates and assumptions and record any adjustments to the preliminary estimates to goodwill provided that we are within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.
Capitalized Software Costs
Capitalization of software development costs for products to be sold to third parties begins upon the establishment of technological feasibility and ceases when the product is available for general release. There is generally no significant passage of time between achievement of technological feasibility and the availability of our software for general release, and the majority of our software is open source. Therefore, we have not capitalized any software costs through January 31, 2021. All software development costs have been charged to research and development expense in the consolidated statements of operations as incurred.
Comprehensive Loss
Comprehensive loss represents the net loss for the period plus the results of certain changes to stockholders’ equity that are not reflected in the consolidated statements of operations.
Revenue Recognition
We generate revenue from subscriptions and services. Subscription revenue relates to term (or time-based) subscription agreements for both open source and propriety software including support and, to a lesser extent, consumption-based revenue from our cloud offerings. Subscription arrangements are typically one to three years in length but may be up to seven years in limited cases. Arrangements with our customers typically do not include general right of returns. Services revenue relates to professional services for the implementation and use of our subscriptions, machine learning expertise and consultation, training and education services and related reimbursable travel costs.
We price our subscription offerings based on the number of servers in a cluster, or nodes, core or edge devices, data under management and/or the scope of support provided and/or on a consumption basis for our cloud-based solutions. Our consulting services are priced primarily on a time and materials basis, and to a lesser extent, a fixed fee basis, and training services are generally priced based on attendance.
We determine revenue recognition through the following steps, which are described in more detail below:
•Identification of the contract or contracts with a customer
•Identification of the performance obligation(s) in the contract
•Determination of the transaction price
•Allocation of the transaction price to the performance obligation(s) in the contract
•Recognition of revenue when, or as, a performance obligation is satisfied
Our agreements with customers often include multiple subscriptions and/or professional services elements, and these elements are sometimes included in separate contracts. We consider an entire customer arrangement to determine if separate contracts entered into at or near the same time should be considered combined for the purposes of revenue recognition. We work with partners in various capacities whereby we are typically responsible for providing the actual product or service as a principal.
At contract inception, we assess the subscription and services product offerings or bundle of product offerings in our contracts to identify performance obligations that are distinct. A performance obligation is distinct when it is separately identifiable from other items in a bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. To identify our performance obligations, we consider all of the product offerings promised in the contract. We have concluded that our contracts with customers do not contain warranties that give rise to a separate performance obligation.
The transaction price is the total amount of consideration we expect to be entitled to in exchange for the product offerings in a contract. Sales, value-added and other taxes we collect from customers concurrent with revenue-producing activities are excluded from revenue. In the instance where our contracts with customers contain variable consideration, we estimate variable consideration primarily using the expected value method.
Once we have determined the transaction price, the total transaction price is allocated to each performance obligation in a manner depicting the amount of consideration to which we expect to be entitled in exchange for transferring the product(s) or service(s) to the customer (allocation objective). If the allocation objective is met at contractual prices, no allocations are performed. Otherwise, we allocate the transaction price to each performance obligation identified in the contract on a relative stand-alone selling price basis.
In order to determine the stand-alone selling price, we conduct a periodic analysis that requires judgment and considers multiple factors that are reasonably available and maximizes the use of observable inputs that may vary over time depending upon the unique facts and circumstances related to each performance obligation. To have observable inputs, we require that a substantial majority of the stand-alone selling prices for a product offering fall within a pricing range. If a directly observable stand-alone selling price does not exist, we estimate a stand-alone selling price range by reviewing external and internal market factor categories, which may include pricing practices, historical discounting, industry practices, service groups and geographic considerations. There is also no hierarchy for how to estimate or otherwise determine the stand-alone selling price for product offerings that are not sold separately, however, we maximize the use of observable data. We believe that this analysis results in an estimate that approximates the price we would charge for the product offerings if they were sold separately.
The following describes the nature of our primary types of revenue and the revenue recognition policies and significant payment terms as they pertain to the types of transactions we enter into with our customers.
Subscription revenue
We sell subscriptions and services for an integrated suite of data analytics and management products. Our subscription offerings are based predominantly on open source software including Spark, Impala, Hive, HBase, Kafka, Hadoop, and more. The open source software is available from the Apache Software Foundation (ASF) or available through an Affero General Public License (AGPL). Certain subscriptions also include licenses of proprietary software that provide additional features and functionality not included in the open source software.
Subscription revenue relates to term (or time-based) subscriptions to our platform, which can include both open source and proprietary software and related support. Subscriptions include internet, email and phone support, bug fixes, and the right to receive unspecified software updates and upgrades released when and if available during the subscription term. Within our subscription arrangements, we account for the license to the proprietary software, if any, and support as two separate performance obligations. As the open source software is publicly available at no cost to the customer, we have determined that there is no value to be assigned to the open source software in our subscription arrangements. The proprietary software license represents a promise to provide a license to use functional intellectual property that is recognized at a point in time on the date access to the software is made available to the customer and the license period has begun. We have concluded the support is a stand-ready performance obligation that consists of a series of distinct days of service that are satisfied ratably over time as the services are provided. We use a time-based output method to measure progress because our efforts are expended evenly throughout the period given the nature of the promise is a stand-ready service. We recognize support revenue ratably, typically beginning on the start of the contractual term of the arrangement.
As part of our support offered under a subscription, we stand ready to help customers resolve technical issues related to the installed platform. The subscriptions are designed to assist throughout a customer’s lifecycle from development to proof-of-concept, to quality assurance and testing, to production and development. Our subscriptions are generally offered under renewable, fixed fee contracts where payments are typically due annually in advance and may have a term of one year or multiple years. The contracts generally do not contain refund provisions for fees earned related to services performed. Unearned subscription revenue is included in contract liabilities. On occasion, we may sell engineering services and/or a premium subscription agreement that provides a customer with development input and the opportunity to work more closely with our developers.
Services revenue
Services revenue is derived primarily from customer fees for consulting services engagements and education services. Our professional services are provided primarily on a time and materials basis and, to a lesser extent, a fixed fee basis, and education services are generally priced based on attendance. Time and material contracts are generally invoiced based upon hours incurred on a monthly basis and fixed fee contracts may be invoiced up-front or as milestones are achieved throughout the project. Services revenue is typically recognized over time as the services are rendered. Depending on the nature of the professional services engagement (e.g., time and materials basis, fixed fee basis, etc.), various measures of progress may be used to recognize revenue. These measures of progress include recognizing revenue in an amount equal to and at the time of invoicing, a measure of time incurred relative to
remaining hours expected to be delivered, or other similar measures. These measures depict our efforts to satisfy services contracts and therefore reflect the transfer of control for the services to a customer.
Contract Assets
Contract assets consist of the right to consideration in exchange for product offerings that we have transferred to a customer when that right is conditional on something other than the passage of time (e.g., performance prior to invoicing on fixed fee service arrangements with substantive acceptance terms). We record unbilled accounts receivable related to revenue recognized in excess of amounts invoiced as we have an unconditional right to invoice and receive payment in the future related to those fulfilled obligations. When we have unconditional rights to consideration, except for the passage of time, a receivable are recorded on the consolidated balance sheets. We do not typically include extended payment terms in our contracts with customers. As of January 31, 2021 and 2020, contract assets were $5.0 million and $4.6 million, respectively, which are included in prepaid expenses and other current assets.
Contract Liabilities
Contract liabilities represent an obligation to transfer product offerings for which we have received consideration, or for which an amount of consideration is due under our contracts with customers and is recognized as revenue as the revenue recognition criteria are met. Our contract balances are reported as net contract assets or liabilities on a contract-by-contract basis at the end of each reporting period.
Other Practical Expedients
We elected to apply a practical expedient related to significant financing components. The practical expedient states that the promised amount of consideration for the effects of a significant financing component is not adjusted if we expect, at contract inception, that the period between when we transfer a promised product offering to a customer and when the customer pays for that product offering will be one year or less.
Contract Costs
Contract costs, consisting primarily of sales commissions and payroll taxes, that are incremental to obtaining a subscription contract with a customer are capitalized and recorded as deferred costs. We expect to recover deferred contract costs over the period of benefit from the underlying contracts. The amortization period for recovery is consistent with the timing of transfer to the customer of services to which the capitalized costs relate. Contract costs that relate to an underlying transaction are expensed commensurate with the recognition of revenue as performance obligations are satisfied. Contract costs that are incurred in excess of those relating to an underlying transaction are not considered commensurate with recognition of revenue as performance obligations are satisfied and are amortized on a straight-line basis over the expected benefit period of five years. Commissions for services are treated as a separate class with a contract duration of less than a year and are expensed as incurred. Deferred contract costs were $84.2 million and $90.0 million as of January 31, 2021 and 2020, respectively. For the years ended January 31, 2021, 2020, and 2019, amortization expense for the deferred contract costs were $66.7 million, $47.6 million and $30.6 million, respectively, and there was no impairment loss in relation to the costs capitalized. We do not incur direct fulfillment-related costs of a nature required to be capitalized and amortized.
Cost of Revenue
Cost of revenue for subscriptions and services is expensed as incurred. Cost of revenue for subscriptions primarily consists of personnel costs such as salaries, bonuses, travel costs, and benefits and stock-based compensation for employees providing technical support for our subscription customers, allocated shared costs (including rent and information technology) and amortization of certain acquired intangible assets from business combinations. Cost of revenue for services primarily consists of personnel costs including salaries, bonuses, benefits and stock-based compensation for employees and fees to subcontractors associated with service contracts, travel costs and allocated shared costs (including rent and information technology).
Research and Development
Research and development costs are expensed as incurred and primarily consist of personnel costs including salaries, bonuses, travel costs, benefits and stock-based compensation for employees, contractor fees, allocated shared costs (including rent and information technology), supplies, and depreciation of equipment associated with the continued development of our platform prior to establishment of technological feasibility and the related maintenance of the existing technology.
Advertising Expenses
Advertising is expensed as incurred. Advertising expense was $11.5 million, $15.4 million, and $6.9 million for the years ended January 31, 2021, 2020 and 2019, respectively.
Stock-Based Compensation
We recognize stock-based compensation expense for all stock-based payments over the requisite service period on a straight-line basis. Employee stock-based compensation cost is estimated at the grant date based on the fair value of the equity for financial reporting purposes. Stock-based compensation expense was recorded based on awards that were ultimately expected to vest, and such expense was reduced for forfeitures as they occurred.
We grant restricted stock units (RSUs) to our employees and members of our board of directors under our 2008 Equity Incentive Plan (2008 Plan) and our 2017 Equity Incentive Plan (2017 Plan). The fair value of RSUs is equal to our stock price at the close of market on the grant date. RSUs granted generally vest upon the satisfaction of a service-based vesting condition only, which is typically satisfied pro-rata over a period of three to four years.
We calculate the fair value of purchase rights granted under the Employee Stock Purchase Plan (ESPP) based on the Black-Scholes option-pricing model. The Black-Scholes model requires the use of various assumptions including expected term and expected stock price volatility. We estimate the expected term based on the offering period, which is six months. We estimate volatility based on historical realized volatility of our stock for the six months prior to issuance. The interest rate is derived from government bonds with a similar term. We have not declared nor do we expect to declare dividends. Therefore, there is no dividend impact on the valuation of ESPP purchase rights.
Income Taxes
We account for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when, in management’s estimate, it is more likely than not that the deferred tax asset will not be realized.
Any liability related to uncertain tax positions is recorded on the financial statements within other liabilities. Penalties and interest expense related to income taxes, including uncertain tax positions, are classified as a component of provision for income taxes, as necessary.
Commitments and Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Recently Adopted Accounting Standards
We adopted the following accounting standards in the first quarter of fiscal 2021:
•Accounting Standards Update (ASU) No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment;
•ASU No. 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which amends ASC 820, Fair Value Measurement; and
• ASU No. 2018-15, Intangibles-Goodwill and Other - Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force)
The adoption of the above listed accounting standards did not have a material impact on our consolidated financial statements for the year ended January 31, 2021.
In June 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13), which requires an entity to utilize a new impairment model known as the current expected credit loss model in place of the currently used incurred loss method. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. For trade receivables, loans, and other financial instruments, an entity will be required to use a forward-looking expected loss model to recognize credit losses that are probable. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. We adopted ASU 2016-13 using the modified retrospective approach as of February 1, 2020. As a result of the adoption, we recorded a $0.8 million adjustment to our beginning accumulated deficit balance to reflect the cumulative effect of the accounting change. The impact of the adoption was not material to our consolidated financial statements as credit losses are not expected to be significant based on historical collection trends, the financial condition of payment partners and external market factors. We will continue to actively monitor the impact of the recent COVID-19 pandemic on expected credit losses.
Recently Issued Accounting Standards
In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs (ASU 2020-08) to provide further clarification and update the previously issued guidance in ASU 2017-08, Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20: Premium Amortization on Purchased Callable Debt Securities” (ASU 2017-08). ASU 2017-08 shortened the amortization period for certain callable debt securities purchased at a premium by requiring that the premium be amortized to the earliest call date. ASU 2020-08 requires that at each reporting period, to the extent that the amortized cost of an individual callable debt security exceeds the amount repayable by the issuer at the next call date, the excess premium shall be amortized to the next call date. ASU 2020-08 is effective for annual reporting periods and interim periods within those years, beginning after December 15, 2020 and to be applied prospectively. We will adopt this standard on February 1, 2021. We do not anticipate that ASU 2020-08 will have a material impact on our consolidated financial statements.
We continue to assess the potential impacts of the new standards, including the area described above, however, we do not know or cannot reasonably estimate quantitative information, beyond that discussed above, related to the impact of the new standard on the consolidated financial statements at this time.
v3.21.1
Revenue from Contracts with Customers
 12 Months Ended
Jan. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Significant changes in contract liabilities during the periods ended January 31, 2021 and 2020 are as follows (in thousands):
February 1, 2019$526,042 
Performance obligations satisfied during the period that were included in the contract liability balance at the beginning of the period(407,004)
Increases due to invoicing prior to satisfaction of performance obligations435,674 
January 31, 2020554,712 
Performance obligations satisfied during the period that were included in the contract liability balance at the beginning of the period(465,351)
Increases due to invoicing prior to satisfaction of performance obligations519,036 
January 31, 2021$608,397 
Remaining Performance Obligations
The transaction price allocated to remaining performance obligations represents contracted revenue that has been billed but not recognized, and unbilled non-cancelable amounts that will be recognized as revenue in future periods. Transaction price allocated to the remaining performance obligation is influenced by several factors, including seasonality, the timing of renewals and average contract terms.
During the year ended January 31, 2021, net revenue recognized from our remaining performance obligations satisfied in previous periods was not material.
As of January 31, 2021, approximately $953.7 million of revenue is expected to be recognized from remaining performance obligations in the amount of approximately $662.2 million over the next 12 months and approximately $291.5 million thereafter.
v3.21.1
Business Combination
 12 Months Ended
Jan. 31, 2021
Business Combinations [Abstract]  
Business Combination Business Combination
On October 8, 2020, we acquired 100% voting interest in Eventador Labs, Inc. (Eventador), a provider of cloud-native services for enterprise-grade stream processing, for aggregate cash consideration of $18.0 million. We believe Eventador will accelerate innovation in our Cloudera DataFlow streaming platform and deliver more business value to our customers in real-time streaming analytics applications.
Under the terms of the agreement, $3.5 million of the aggregate consideration is payable to the former employees and is contingent upon their continued employment. As a result, these payments will be recorded as compensation expense over the contractual term of three years. Purchase consideration of $14.5 million has been preliminarily allocated primarily to goodwill and intangible assets of $8.9 million and $5.7 million, respectively. The intangible assets are being amortized over their respective useful lives ranging from 4 to 5 years.
The results of operations of Eventador have been included in our consolidated statements of operations from the acquisition date and were not material.
v3.21.1
Cash Equivalents and Marketable Securities
 12 Months Ended
Jan. 31, 2021
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
The following are the fair values of our cash equivalents and marketable securities as of January 31, 2021 (in thousands):
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$186,127 $— $— $186,127 
Certificates of deposit4,000 — — 4,000 
Marketable securities:
U.S. agency obligations68,972 76 (4)69,044 
Asset-backed securities2,901 2 — 2,903 
Corporate notes and obligations210,321 1,215 (72)211,464 
Commercial paper48,212 19 (6)48,225 
Municipal securities40,031 213 (5)40,239 
Certificates of deposit60,749 53 — 60,802 
U.S. treasury securities38,291 34 — 38,325 
Total cash equivalents and marketable securities$659,604 $1,612 $(87)$661,129 

The following are the fair values of our cash equivalents and marketable securities as of January 31, 2020 (in thousands):
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$34,596 $— $— $34,596 
Marketable securities:
Asset-backed securities68,194 235 — 68,429 
Corporate notes and obligations199,226 891 — 200,117 
Commercial paper46,460 7 — 46,467 
Municipal securities20,865 65 — 20,930 
Certificates of deposit14,996 19 — 15,015 
U.S. treasury securities24,563 33 — 24,596 
Total cash equivalents and marketable securities$408,900 $1,250 $— $410,150 

Maturities of our noncurrent marketable securities generally range from one year to three years at both January 31, 2021 and 2020.
The contractual maturities of cash equivalents and marketable securities were as follows (in thousands):
January 31, 2021January 31, 2020
Amortized CostEstimated Fair ValueAmortized CostEstimated Fair Value
Due within one year$487,201 $487,848 $273,582 $274,058 
Due after one year through five years172,403 173,281 135,318 136,092 
Total cash equivalents and marketable securities$659,604 $661,129 $408,900 $410,150 

The unrealized loss for each of these fixed rate marketable securities was not material as of January 31, 2021 and 2020. The unrealized losses on these investments were primarily due to changes in market interest rates. We expect to receive the full principal and interest on all of these marketable securities and have the ability and intent to hold these investments until a recovery of fair value. We determined that no credit losses related to our marketable securities was required for the year ended January 31, 2021, 2020 and 2019.
Realized gains and realized losses on our cash equivalents and marketable securities are included in other income (expense), net on the consolidated statement of operations and were not material for the years ended January 31, 2021, 2020 and 2019.
Reclassification adjustments out of accumulated other comprehensive loss into net loss were not material for the years ended January 31, 2021 and 2020.
v3.21.1
Fair Value Measurement
 12 Months Ended
Jan. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair Value Measurement
Our financial assets and liabilities consist principally of cash and cash equivalents, marketable securities, accounts receivable, and accounts payable. We measure and record certain financial assets and liabilities at fair value on a recurring basis. The estimated fair value of accounts receivable and accounts payable approximates their carrying value due to their short-term nature. Cash equivalents and marketable securities are recorded at estimated fair value.
All of our cash equivalents and marketable securities are classified within Level 1 or Level 2 because the cash equivalents and marketable securities are valued using quoted market prices or alternative pricing sources and models utilizing observable market inputs.
We follow a three-level valuation hierarchy for disclosure of fair value measurements as follows:
Level 1      Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.
Level 2      Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
Level 3      Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
Assets Measured at Fair Value on a Recurring Basis
The following table represents our financial assets according to the fair value hierarchy, measured at fair value as of January 31, 2021 (in thousands):
Level 1Level 2Total
Financial assets:
Money market funds $186,127 $— $186,127 
U.S. agency obligations — 69,044 69,044 
Asset-backed securities — 2,903 2,903 
Corporate notes and obligations — 211,464 211,464 
Commercial paper — 48,225 48,225 
Municipal securities — 40,239 40,239 
Certificates of deposit— 64,802 64,802 
U.S. treasury securities— 38,325 38,325 
Total financial assets$186,127 $475,002 $661,129 
The following table represents our financial assets according to the fair value hierarchy, measured at fair value as of January 31, 2020 (in thousands):
Level 1Level 2Total
Financial assets:
Money market funds $34,596 $— $34,596 
Asset-backed securities — 68,429 68,429 
Corporate notes and obligations — 200,117 200,117 
Commercial paper — 46,467 46,467 
Municipal securities — 20,930 20,930 
Certificates of deposit — 15,015 15,015 
U.S. treasury securities— 24,596 24,596 
Total financial assets$34,596 $375,554 $410,150 

We value our Level 1 assets using quoted prices in active markets for identical instruments. We value our Level 2 assets with the help of a third-party pricing service using quoted market prices for similar instruments, nonbinding market prices that are corroborated by observable market data, or pricing models such as discounted cash flow techniques. We use such pricing data as the primary input, to which we have not made any material adjustments during the periods presented, to make our determination and assessments as to the ultimate valuation of these assets.
Our foreign currency forward contract liabilities and assets are classified within Level 2 in the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, including currency spot and forward rates. The fair value of these contracts were not material as of January 31, 2021.
We have no Level 1 or 3 liabilities and no Level 3 assets measured on a recurring basis.
Assets Measured at Fair Value on a Nonrecurring Basis
Certain of our long-lived assets, including intangible assets, goodwill, and ROU assets are measured at fair value on a nonrecurring basis when there are indicators of impairment. In the fourth quarter of fiscal year 2021, we recorded impairment charges of $35.8 million on lease related ROU assets and other long-lived assets primarily related to certain office leases that we determined will no longer be used. The impairment was derived by comparing the fair value of the impacted assets to the carrying value of those assets as of the impairment measurement date, as required under ASC Topic 360 using Level 3 inputs. See Note 10 for additional discussion related to these impairment charges. There were no impairment charges recognized during the years ended January 31, 2020 and 2019.
v3.21.1
Goodwill and Intangible Assets
 12 Months Ended
Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
The following table represents the changes to goodwill (in thousands):
Balance at January 31, 2019$586,456 
Other (1)
3,905 
Balance at January 31, 2020590,361 
Eventador acquisition8,930 
Balance at January 31, 2021$599,291 
(1) Other consists of certain purchase accounting adjustments related to our merger with Hortonworks in January 2019 and to an immaterial business combination.
Intangible Assets
Intangible assets consisted of the following as of January 31, 2021 (in thousands):
Gross Fair
Value		Accumulated
Amortization		Net Book
Value		Weighted Average
Remaining Useful Life
(in years)
Developed technology$22,770 $(14,814)$7,956 3.3
Customer relationships and other acquired intangible assets671,947 (147,273)524,674 7.9
Unbilled contracts18,300 (18,300)— — 
Total$713,017 $(180,387)$532,630 7.8

Intangible assets consisted of the following as of January 31, 2020 (in thousands):
Gross Fair
Value		Accumulated
Amortization		Net Book
Value		Weighted Average
Remaining Useful Life
(in years)
Developed technology$17,570 $(11,321)$6,249 2.0
Customer relationships and other acquired intangible assets671,447 (80,847)590,600 8.9
Unbilled contracts18,300 (9,913)8,387 0.9
Total$707,317 $(102,081)$605,236 8.7
Amortization expense for intangible assets was $78.3 million, $80.0 million and $9.1 million during the years ended January 31, 2021, 2020 and 2019, respectively. The significant increase in fiscal 2020 relates to the amortization of intangible assets recognized as part of our merger with Hortonworks in January 2019.
The expected future amortization expense of these intangible assets as of January 31, 2021 is as follows (in thousands):
2022$70,239 
202367,887 
202467,376 
202567,286 
202666,875 
2027 and thereafter192,967 
Total amortization expense$532,630 
v3.21.1
Derivative Contracts
 12 Months Ended
Jan. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Contracts Derivative Contracts We generate revenues and incur expenses in numerous currencies and are exposed to foreign currency risk. To mitigate the impact of changes in foreign currency rates, we execute foreign currency forward contracts to offset the gains and losses on foreign currency denominated monetary assets and liabilities. The duration of our foreign currency forward contracts is less than 12 months. We do not enter into any derivatives for trading or speculative purposes.During the year ended January 31, 2021, we recorded a loss of $1.0 million in other income (expense), net within our consolidated statements of operations and is reported as part of other adjustments to reconcile net loss to net cash provided by operating activities in the consolidated statements of cash flows. As of January 31, 2021, we had outstanding foreign currency forward contracts not designated as hedges with a total notional value of $18.7 million.
v3.21.1
Balance Sheet Components
 12 Months Ended
Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Property and Equipment, Net
The cost and accumulated depreciation and amortization of property and equipment are as follows (in thousands):
As of January 31,
20212020
Computer equipment and software $24,974 $22,489 
Office furniture and equipment 13,352 12,672 
Leasehold improvements 24,719 24,236 
Property and equipment, gross 63,045 59,397 
Less: accumulated depreciation and amortization (44,980)(37,409)
Property and equipment, net $18,065 $21,988 
Depreciation expense was $11.1 million, $12.1 million and $8.3 million for the years ended January 31, 2021, 2020 and 2019, respectively.
Accrued Compensation
Accrued compensation consists of the following (in thousands):
As of January 31,
20212020
Accrued salaries, benefits and commissions$22,538 $27,067 
Accrued compensation-related taxes10,834 15,205 
Accrued bonuses 14,956 13,409 
Employee stock purchase plan withholdings2,634 2,732 
Other (1)
5,681 3,413 
Total accrued compensation $56,643 $61,826 
(1) Other consists primarily of amounts owed for severance-related benefits.
Other Accrued Liabilities
Other accrued liabilities consist of the following (in thousands):
As of January 31,
20212020
Accrued professional costs $3,790 $6,182 
Current portion of debt3,610 — 
Accrued taxes 5,596 5,164 
Accrued self-insurance costs 4,720 1,743 
Acquisition related holdback payments (1)
3,368 — 
Other (2)
9,112 9,208 
Total other accrued liabilities $30,196 $22,297 
(1) Business combination related payments held by Cloudera for indemnification purposes.
(2) Other relates primarily to amounts owed to third-party vendors that provide marketing, cloud-computing services and travel costs.
v3.21.1
Debt
 12 Months Ended
Jan. 31, 2021
Debt Disclosure [Abstract]  
Debt Debt
On December 22, 2020, we entered into a senior secured credit agreement (the “Credit Agreement”). The Credit Agreement provides for a seven-year senior secured institutional term loan "B" for an aggregate principal amount of $500.0 million (the "Term Loan"). The Term Loan amortizes at a per annum rate equal to 1.0% payable quarterly, with the balance payable at maturity on December 22, 2027. The proceeds of the Term Loan will be used for general corporate purposes, including to fund repurchases of our common stock and to pay transaction costs and expenses in connection therewith.
At our option, the Term Loan will bear interest at a per annum rate equal to a Eurocurrency Rate plus 2.50% or a Base Rate plus 1.50%, both subject to a 3.25% floor. As of January 31, 2021, the Term Loan is bearing interest at a per annum rate of 3.25%. During the year ended January 31, 2021, we recognized interest expense of $1.7 million.
The Credit Agreement contains usual and customary representations and warranties, optional and mandatory prepayment provisions, and affirmative and negative covenants, including limitations on liens, investments, restricted payments, additional indebtedness, transactions with affiliates and asset sales and mergers. The Credit Agreement does not contain any financial covenants. Our obligations under the Credit Agreement may be accelerated upon customary events of default, including non-payment of principal, interest, fees and other amounts, inaccuracy of representations and warranties, violation of covenants, cross default and cross acceleration to material third party indebtedness, voluntary and involuntary bankruptcy or insolvency proceedings, inability to pay debts as they become due, material judgments, ERISA events, actual or asserted invalidity of security documents or guarantees and change in control.
We incurred debt discount and issuance costs of approximately $9.5 million in connection with obtaining our Term Loan. These debt discount and issuance costs are amortized on a straight-line basis, which approximates the effective interest rate method, to interest expense over the contractual term of the arrangement. Amortization of debt discount and issuance costs during the year ended January 31, 2021 was immaterial.
As of January 31, 2021, the Term Loan had a carrying value of $490.7 million, of which $3.6 million is classified as current and recorded in other accrued liabilities and $487.1 million is classified as non-current on the consolidated balance sheet.
As of January 31, 2021, the expected future principal payments under the Term Loan are due as follows (in thousands):
2022$5,000 
20235,000 
20245,000 
20255,000 
20265,000 
2027 and thereafter475,000 
Total $500,000 
v3.21.1
Leases
 12 Months Ended
Jan. 31, 2021
Leases [Abstract]  
Leases Leases
We have entered into various non-cancelable operating lease agreements for our facilities. Our leases have various expiration dates through September 2031. Many leases include one or more options to renew. We do not assume renewals in our determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement.
Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The lease term is determined to be the non-cancelable period including any lessee renewal options which are considered to be reasonably certain of exercise. The interest rate implicit in the lease contracts is typically not readily determinable. As such, we utilized the appropriate incremental borrowing rate based on information available at the commencement date, which is the rate incurred to borrow on a collateralized basis over a similar term in a similar economic environment.
Components of lease expense are summarized as follows (in thousands):
Years Ended January 31,
20212020
Operating lease cost $45,747 $45,640 
Short-term lease cost1,782 2,276 
Sublease income(14,730)(15,730)
Net lease cost (1)
$32,799 $32,186 
(1) Amount excludes ROU asset impairment charge of $35.8 million, as discussed below.
Lease term and discount rate information are summarized as follows:
As of January 31,
20212020
Weighted Average Remaining Lease Term (years)6.16.8
Weighted Average Discount Rate5.9 %6.0 %
Maturities of lease liabilities as of January 31, 2021 are as follows (in thousands):
Minimum Lease Payments, Gross
2022$28,355 
202337,811 
202437,846 
202536,997 
202633,317 
2027 and thereafter55,243 
Total lease payments$229,569 
     Less imputed interest(40,699)
Present value of lease liabilities$188,870 
We expect to receive $14.5 million of sublease rental proceeds over the next two years as of January 31, 2021.
In the fourth quarter of fiscal year 2021, as a result and in consideration of the changing nature of our use of office space for our workforce and the impacts of the COVID-19 pandemic, we evaluated our existing real estate lease portfolio. This evaluation included the decision to abandon a leased office space and the establishment of a formal plan to cease-use and sublease certain other leased office spaces that we no longer utilize. In connection with this evaluation, we reviewed certain of our lease right-of-use assets and related other long-lived assets for impairment under ASC 360.
As a result of the evaluation, we recognized an impairment loss during the fourth quarter of fiscal year 2021 of $35.8 million, which is included in general and administrative expenses in the accompanying statement of operations for the year ended January 31, 2021. The impairment loss recorded includes $34.0 million related to lease right-of-use assets and $1.8 million related to other long-lived assets namely leasehold improvements and IT infrastructure.
The fair values for the asset groups relating to the impaired long-lived assets were estimated primarily using discounted cash flow models (income approach) with Level 3 inputs. The significant assumptions used in estimating fair value include the expected downtime prior to the commencement of future subleases, projected sublease income over the remaining lease periods and discount rates that reflect the level of risk associated with receiving future cash flows.
v3.21.1
Commitments and Contingencies
 12 Months Ended
Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Letters of Credit
As of January 31, 2021 and 2020, we had a total of $19.4 million and $19.9 million, respectively, in letters of credit outstanding in favor of certain landlords for office space. These letters of credit renew annually and expire at various dates through 2027.
Legal Proceedings
On June 7, 2019, a purported class action complaint was filed in the United States District Court for the Northern District of California, entitled Christie v. Cloudera, Inc., et al., Case No. 5:19-cv-3221-LHK. The complaint named as defendants Cloudera, its former Chief Executive Officer, its Chief Financial Officer and a former officer and director, asserting alleged class claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (Exchange Act) and SEC Rule 10b-5. Two substantially similar class action complaints, entitled Zarantonello v. Cloudera, Inc., et al., Case No. 5:19-cv-4007-LHK, and Dvornic v. Cloudera, Inc., et al., Case No. 5:19-cv-4310-LHK, were subsequently filed against the same defendants in the same court on July 12, 2019 and July 26, 2019, respectively. The suits have been consolidated under the name, In re Cloudera, Inc. Securities Litigation, Case No. 5:19-cv-3221-LHK. The court subsequently appointed lead plaintiffs and lead counsel, and a consolidated complaint was filed on February 14, 2020. On March 18, 2020, the court vacated its prior order appointing lead plaintiffs and lead counsel and reopened the lead plaintiff process. On July 27, 2020, the court appointed new lead plaintiffs and lead counsel. On September 22, 2020, lead plaintiffs filed a consolidated amended complaint. The consolidated amended complaint asserts claims against Cloudera and four individual defendants under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5, based on allegedly false and misleading statements between April 28, 2017 and June 5, 2019. The consolidated amended complaint also asserts claims against Cloudera, Intel Corporation, and fourteen current and former officers and directors under the Securities Act of 1933, on behalf of all persons who acquired Cloudera stock pursuant or traceable to the S-4 registration statement filed in connection with Cloudera’s January 2019 merger with Hortonworks, and alleges that the registration statement contained untrue statements of material fact and omitted material facts. On October 16, 2020, two additional plaintiffs filed a motion to intervene seeking permission to file an additional class action complaint alleging claims under the Securities Act of 1933. The court has not yet ruled on that motion. On October 27, 2020, defendants filed motions to dismiss the consolidated amended complaint. A hearing on the motions to dismiss is currently scheduled for April 1, 2021. Cloudera believes that the allegations in the lawsuits are without merit.
On June 7, 2019, a purported class action complaint was filed in the Superior Court of California, County of Santa Clara, entitled Lazard v. Cloudera, Inc., et al., Case No. 19CV348674. The complaint named as defendants Cloudera, thirteen individuals who are current or former directors or officers of Cloudera, and Intel Corporation. Two substantially similar suits, entitled Franchi v. Cloudera, Inc., et al., Case No. 19CV348790, and Cannizzo v. Cloudera, Inc., et al., Case No. 19CV348974, were subsequently filed in the same court on June 11, 2019 and June 14, 2019, respectively. The suits have been consolidated under the name In re Cloudera, Inc. Securities Litigation, Lead Case No. 19CV348674 and the consolidated amended complaint purports to assert claims under Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 on behalf of all persons who acquired Cloudera stock pursuant or traceable to the S-4 registration statement filed in connection with Cloudera’s January 2019 merger with Hortonworks. The consolidated amended complaint alleges that the registration statement contained untrue statements of material fact and omitted material facts. Plaintiffs seek, among other things, an award of damages and attorneys’ fees and costs. On July 1, 2020, the court overruled Cloudera's demurrer to the consolidated amended complaint. On August 18, 2020, a purported shareholder class action captioned Stahl v. Cloudera, Inc., et al., Case No. 20CV369480 was filed in the Superior Court of California, County of Santa Clara, and was subsequently consolidated into the lead case. On November 5, 2020, the court entered a stipulated order certifying a class consisting of all persons who acquired Cloudera common stock in exchange for Hortonworks securities pursuant to the registration statement and prospectus issued in connection with Cloudera’s January 2019 merger and acquisition of Hortonworks. A further case management conference is currently scheduled for June 9, 2021. Cloudera believes that the allegations in the lawsuits are without merit.

On July 30, 2019, a purported shareholder derivative complaint was filed in the United States District Court for the District of Delaware, entitled Lee, et al. v. Cole, et al., Case No. 1:19-cv-01422-LPS. The complaint names as defendants eleven individuals who are current or former directors or officers of Cloudera, names Cloudera as a nominal defendant, and purports to assert claims on Cloudera’s behalf against the individual defendants for breach of fiduciary duty, unjust enrichment, and alleged violation of Sections 10(b) and 20(a) of the Exchange Act. On September 5, 2019, a purported shareholder derivative complaint was filed in the United States District Court for the District of Delaware, entitled Slattery v. Reilly, et al., Case No. 1:19-cv-01662-LPS. The complaint names as defendants thirteen individuals who are current or former directors or officers of Cloudera, names Cloudera as a
nominal defendant, and purports to assert claims on Cloudera’s behalf against the individual defendants for breach of fiduciary duty, unjust enrichment, and alleged violations of Section 10(b), 14 and 20(a) of the Exchange Act. On October 16, 2019, a purported shareholder derivative complaint was filed in the United States District Court for the District of Delaware, entitled Frentzel v. Bearden, et al., Case No. 1:19-cv-01962-LPS. The complaint names as defendants thirteen individuals who are current or former directors or officers of Cloudera, and names Cloudera as a nominal defendant. The complaint purports to assert claims on Cloudera’s behalf against the individual defendants for breach of fiduciary duty, alleged violations of Section 14 of the Exchange Act, insider selling and misappropriation of information. All three derivative actions are based on allegations that are substantially similar to those in the class actions filed in the United States District Court for the Northern District of California, described above. All three derivative actions seek, among other things, an award of damages on behalf of Cloudera, corporate governance reforms and attorneys’ fees and costs. The Slattery and Frentzel actions additionally seek disgorgement on behalf of Cloudera. The suits have been consolidated under the name, In re Cloudera, Inc. Stockholder Derivative Litigation, Case No. 1:19-cv-01422-LPS. A consolidated amended complaint has not yet been filed and the case is currently stayed.

On September 3, 2019, a purported shareholder derivative complaint was filed in the United States District Court for the Northern District of California, entitled Chen v. Reilly, et al., Case No. 5:19-cv-05536-LHK. That complaint names as defendants thirteen individuals who are current or former directors or officers of Cloudera, names Cloudera as a nominal defendant, and purports to assert claims on Cloudera’s behalf against the individual defendants for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and alleged violation of Section 14(a) of the Exchange Act. On September 10, 2019, a purported shareholder derivative complaint that is substantially similar to the Chen action and is brought against the same defendants, was filed in the United States District Court for the Northern District of California, entitled Fu v. Reilly, et al., Case No. 5:19-cv-05705-LHK. Both derivative actions are based on allegations that are substantially similar to those in the class actions filed in the United States District Court for the Northern District of California, described above. Both derivative actions seek, among other things, an award of damages on behalf of Cloudera, corporate governance reforms and attorneys’ fees and costs. The suits have been consolidated under the name, In re Cloudera, Inc. Derivative Litigation, Case No. 5:19-cv-05536-LHK. A consolidated amended complaint has not yet been filed, and the case is currently stayed.

In the ordinary course of business, we are or may be involved in a variety of litigation matters, suits, investigations, and proceedings, including actions with respect to intellectual property claims, government investigations, labor and employment claims, breach of contract claims, tax, and other matters. Regardless of the outcome, these litigation matters can have an adverse impact on us because of defense costs, diversion of management resources, harm to reputation, and other factors. Future litigation may be necessary to defend ourselves, or our customers or partners on indemnity matters, by determining the scope, enforceability and validity of third-party proprietary rights or by establishing our proprietary rights. Further, the ultimate outcome of any litigation is uncertain and, regardless of outcome, litigation can have an adverse impact on us because of defense costs, potential negative publicity, diversion of management resources and other factors. While we are not aware of other pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on our business, consolidated financial position, results of operations or cash flows, our analysis of whether a claim may proceed to litigation cannot be predicted with certainty, nor can the results of litigation be predicted with certainty. Accordingly, there can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows in a particular period or subject us to an injunction that could seriously harm our business.
We record a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to our outstanding legal matters, our management believes that the amount or estimable range of possible loss will not, either individually or in the aggregate, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of litigation is inherently uncertain. Therefore, if one or more of these legal matters were resolved against us for amounts in excess of management’s expectations, our results of operations and financial condition including in a particular reporting period, could be materially adversely affected.
Indemnification
From time to time, we enter into certain types of contracts that contingently require us to indemnify various parties against claims from third parties. These contracts primarily relate to (i) certain real estate leases under which we may be required to indemnify property owners for environmental and other liabilities and other claims arising from our use of the applicable premises, (ii) our amended and restated bylaws, under which we must indemnify directors and executive officers, and may indemnify other officers and employees, for liabilities arising out of their relationship with us, (iii) contracts under which we must indemnify directors and certain officers for liabilities arising out of their relationship with us, (iv) contracts under which we may be required to indemnify customers or partners against certain claims, including claims from third parties asserting, among other things, infringement of their intellectual property rights, and (v) procurement, consulting, or license agreements under which we may be required to indemnify vendors, consultants or licensors for certain claims, including claims that may be brought against them arising from our acts or omissions with respect to the supplied products, technology or services. From time to time, we may receive indemnification claims under these contracts in the normal course of business. In addition, under these contracts we may have to modify the accused infringing intellectual property and/or refund amounts received.
In the event that one or more of these matters were to result in a claim against us, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on our future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.
We maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors and certain officers.
To date, we have not incurred any material costs, and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.
v3.21.1
Common Stock Repurchases
 12 Months Ended
Jan. 31, 2021
Equity [Abstract]  
Common Stock Common Stock RepurchasesOn March 3, 2020, our board of directors authorized a share repurchase program of up to $100 million of our outstanding shares of common stock. Under this share repurchase program, we used $26.0 million to repurchase 3.9 million shares of common stock at an average repurchase price of $6.56 per share during the year ended January 31, 2021. On December 2, 2020, our board of directors authorized another share repurchase program of up to $500 million of our outstanding shares of common stock. Under this share repurchase program, we used $314.1 million to repurchase 26.1 million shares of common stock from Intel Corporation at an average repurchase price of $12.05 per share during the year ended January 31, 2021. There were approximately $259.9 million of authorized funds remaining under both share repurchase programs as of January 31, 2021.Under both share repurchase programs, shares may be repurchased through open market purchases, block trades and/or privately negotiated transactions in compliance with Rule 10b-18 promulgated under the Exchange Act, subject to market conditions, applicable legal requirements, and other relevant factors. Repurchases may also be made under Rule 10b5-1 plans, which permit shares of common stock to be repurchased through pre-determined criteria. The timing, volume and nature of any repurchases will be at the discretion of our management based on their evaluation of our capital needs, market conditions, applicable legal requirements and other factors. The programs do not have an expiration date and may be suspended or discontinued at any time and do not obligate us to purchase any shares.
v3.21.1
Stock Based Compensation
 12 Months Ended
Jan. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation We maintain two stock-based compensation plans: the 2017 Equity Incentive Plan (2017 Plan), and the 2008 Equity Incentive Plan (2008 Plan), collectively referred to as the Stock Plans. We do not expect to grant any
additional awards under the 2008 Plan. Outstanding awards under the 2008 Plan continue to be subject to the terms and conditions of the 2008 Plan.
When we adopted the 2017 Plan in March 2017, we reserved 30,000,000 shares of our common stock for issuance, plus an additional number of shares of common stock equal to any shares reserved but not issued or subject to outstanding awards under our 2008 Plan on the effective date of our 2017 Plan, plus, on and after the effective date of our 2017 Plan, (i) shares that are subject to outstanding awards under the 2008 Plan which cease to be subject to such awards, (ii) shares issued under the 2008 Plan which are forfeited or repurchased at their original issue price, and (iii) shares subject to awards under the 2008 Plan that are used to pay the exercise price of an option or withheld to satisfy the tax withholding obligations related to any award. The number of shares reserved for issuance under our 2017 Plan will increase automatically on the first day of February of each calendar year during the term of the 2017 Plan by a number of shares of common stock equal to the lesser of (i) 5% of the total outstanding shares of our common stock as of the immediately preceding January 31 or (ii) a number of shares determined by our board of directors. On February 1, 2021, 14,561,036 additional shares were authorized for issuance by the board of directors. As of January 31, 2021, there were 13,720,801 shares of common stock reserved and available for future issuance under the Stock Plans.
As a result of the Hortonworks merger in January 2019, the total fair value of the stock-based awards assumed was $63.5 million, which was recognized as stock-based compensation expense over a weighted-average period of 1.5 years from the acquisition date. Additionally, we recognized $13.1 million of stock-based compensation expense during the year ended January 31, 2019 due to the acceleration and modification of certain employee awards assumed as part of the Hortonworks merger.
During the years ended January 31, 2021 and 2020, we incurred approximately $6.6 million and $20.9 million, respectively, of additional stock-based compensation expense related to the acceleration and modification of stock awards held by certain former employees and former board members.
Stock Options
Stock options granted generally have a maximum term of ten years from the grant date, are exercisable upon vesting unless otherwise designated for early exercise by the board of directors at the time of grant, and generally vest over a period of three to four years, with 25% vesting after one year and then ratably on a monthly basis for the remaining two to three years.
The following table summarizes stock option activity and related information under the Stock Plans:
Options Outstanding
Options
Outstanding (in thousands)		Weighted-
Average
Exercise
Price		Weighted-Average Remaining
Contractual
Term
(Years)		Aggregate
Intrinsic
Value
(in thousands)
Balance — January 31, 202013,530 $5.96 2.1$70,057 
Exercised
(9,197)3.89 —— 
Canceled
(950)14.22 —— 
Balance — January 31, 20213,383 $9.27 3.0$21,982 
Exercisable— January 31, 20213,382 $9.27 3.0$21,982 
Vested and Expected to Vest — January 31, 20213,383 $9.27 3.0$21,982 

The total intrinsic value of options exercised during the years ended January 31, 2021, 2020 and 2019 was $75.8 million, $26.2 million and $31.2 million, respectively. The intrinsic value is the difference between the current fair market value of the stock for accounting purposes at the time of exercise and the exercise price of the stock option.
The total grant-date fair value of stock options vested during the years ended January 31, 2021, 2020 and 2019 was $0.4 million, $1.6 million and $27.9 million, respectively. There were no options granted during the year ended January 31, 2021 and 2020. The weighted-average grant-date fair value of employee options granted during the years ended January 31, 2019 was $4.58 per share.
The fair value of each stock option grant was estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Year Ended January 31, 2019
Volatility 45.0%
Risk-free interest rate 2.5%
Expected term (in years) 5.0 years
Expected dividends —%
The unamortized stock-based compensation expense for stock options was immaterial at January 31, 2021.
Restricted Stock Units
We issue RSUs to employees and directors under the Stock Plans. RSUs vest upon the satisfaction of a service-based vesting condition only. The service-based condition for the majority of these awards is generally satisfied pro-rata over three-to-four years. For new employee grants, the RSUs generally meet the service-based condition over a four-year period, with 25% met after one year and then ratably on a quarterly basis for the remaining three years. For continuing employee grants, the RSUs generally meet the service-based condition pro-rata quarterly over a period of three years.
The following table summarizes RSU activity and related information under the Stock Plans:
RSUs Outstanding
Number of RSUs (in thousands)Weighted-Average Grant Date Fair Value Per Share
Balance —January 31, 202038,584 $10.85 
Granted 23,097 11.98 
Canceled (6,858)11.38 
Vested (20,059)10.14 
Balance —January 31, 202134,764 $11.91 

The weighted-average grant date fair value of RSUs granted during the years ended January 31, 2021, 2020 and 2019 was $11.98, $8.96, and $12.08 per share, respectively. The total fair value of RSUs vested during the years ended January 31, 2021, 2020 and 2019 was $216.1 million, $218.3 million, and $128.7 million, respectively.
The unamortized stock-based compensation expense for RSUs was $381.9 million as of January 31, 2021 and will be recognized over the average remaining vesting period of 2.3 years.
In February 2021, our Compensation Committee authorized the granting of RSUs and performance-based restricted stock units (PRSUs) to certain executives under the 2017 Plan. See Note 18 for further details.
Employee Stock Purchase Plan
Our ESPP is intended to qualify as an employee stock purchase plan under Section 423 of the United States Internal Revenue Code of 1986, as amended (Code). Purchases will be accomplished through participation in discrete offering periods. Each offering period consists of a six-month purchase period (commencing each June 21 and December 21).
Under our ESPP, eligible employees will be able to acquire shares of our common stock by accumulating funds through payroll deductions. Our employees generally are eligible to participate in our ESPP if they are employed by us for at least 20 hours per week and more than five months in a calendar year. Employees who are 5% stockholders or would become 5% stockholders as a result of their participation in our ESPP, are ineligible to participate in our ESPP. We may impose additional restrictions on eligibility. Our eligible employees are able to select a rate of payroll deduction between 1% and 15% of their base cash compensation. The purchase price for shares of our common stock purchased under our ESPP is 85% of the lesser of the fair market value of our common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. No participant has the right to purchase shares of our common stock in an amount, when aggregated with purchase rights under all our employee stock purchase plans that are also in effect in the same calendar year(s), that has a fair market value of more than $25,000, determined as of the first day of the applicable purchase period, for each calendar year in which that right is outstanding. In addition, no participant is permitted to purchase more than 2,500 shares during any one purchase period or such lesser amount determined by our compensation committee or our board of directors. Once an employee is enrolled in our ESPP, participation will be automatic in subsequent offering periods. An employee’s participation automatically ends upon termination of employment for any reason.
We initially reserved 3,000,000 shares of our common stock for issuance under our ESPP. The number of shares reserved for issuance under our ESPP increases automatically on February 1 of each of the first 10 calendar years following the first offering date by the number of shares equal to the lesser of (i) 1% of the total outstanding shares of our common stock as of the immediately preceding January 31 (rounded to the nearest whole share) or (ii) a number of shares of our common stock determined by our board of directors. On February 1, 2021, 2,912,207 additional shares were authorized for issuance by the board of directors. As of January 31, 2021, the total number of shares available for grant under the ESPP was 4,344,158 shares.
As of January 31, 2021, $2.6 million was withheld on behalf of employees for a future purchase under the ESPP and is recorded in accrued compensation in our consolidated balance sheets. See Note 8 for additional information.
The fair value of each ESPP grant was estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Years Ended January 31,
202120202019
Volatility
66.8%31.9%38.8%
Risk-free interest rate
0.1%1.9%2.4%
Expected term (in years)
0.5 years0.5 years0.5 years
Expected dividends
—%—%—%
v3.21.1
Income Taxes
 12 Months Ended
Jan. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The domestic and foreign components of loss before provision for income taxes consisted of the following (in thousands):
Years Ended January 31,
202120202019
Domestic $(168,327)$(340,542)$(191,479)
Foreign 12,939 12,660 4,248 
Net loss before provision for income taxes $(155,388)$(327,882)$(187,231)

The components of provision for income taxes are as follows (in thousands):
Years Ended January 31,
202120202019
Current:
   Federal $— $— $— 
   State (16)(18)(106)
   Foreign (9,179)(8,766)(5,371)
Total (9,195)(8,784)(5,477)
Deferred:
   Federal 302 — — 
   State — — — 
   Foreign 1,547 84 59 
Total 1,849 84 59 
Total provision for income taxes $(7,346)$(8,700)$(5,418)

A reconciliation of income taxes at the statutory federal income tax rate to the provision for income taxes included in the consolidated statements of operations is as follows (in thousands):
Years Ended January 31,
202120202019
U.S. federal statutory income tax $32,631 $68,856 $39,318 
Research tax credits 5,066 6,120 10,044 
Stock-based compensation 11,486 (6,395)(3,004)
Change in U.S. tax status of foreign entities (1)
1,646 (72,449)— 
Change in valuation allowance
(50,529)8,566 (42,450)
Foreign tax rate differential(5,507)(6,384)(4,945)
Legal expenses— — (4,000)
Global intangible low-taxed income— (3,668)— 
Non-deductible compensation(2,305)(1,150)— 
Other 166 (2,196)(381)
Provision for income taxes $(7,346)$(8,700)$(5,418)
(1) The change in U.S. tax status of foreign entities pertains to changes we made to our corporate entity operating structure, primarily as it pertains to transferring certain acquired intellectual property to the U.S. in fiscal 2020. As a result, certain foreign entities became disregarded for U.S. tax purposes. This change required the remeasurement of certain deferred taxes at tax rates different to those outside of the U.S. and the establishment of new deferred taxes for the disregarded entities, resulting in a one-time increase in our effective tax rate. Any tax provision impact was fully offset by a valuation allowance.
The deferred tax assets and liabilities were as follows (in thousands):
As of January 31,
20212020
Deferred tax assets:
   Accruals and reserves $13,079 $7,948 
   Deferred revenue 20,967 28,621 
   Net operating loss carryforwards 479,157 475,390 
   Research and development credits and other credits 84,278 75,168 
   Stock-based compensation 8,626 18,428 
 ROU assets/lease liability49,406 53,048 
   Capitalized research and development 52,532 10,351 
   Gross deferred tax assets 708,045 668,954 
Less valuation allowance (525,381)(459,649)
Total deferred tax assets, net of valuation allowance 182,664 209,305 
Deferred tax liabilities:
   Depreciation and amortization (124,773)(139,176)
ROU assets/lease liability(35,157)(48,085)
   Deferred costs(20,741)(21,609)
Gross deferred tax liabilities (180,671)(208,870)
Net deferred tax assets $1,993 $435 

Undistributed earnings of our foreign subsidiaries at January 31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for federal and state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (GILTI) regimes as enacted by the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act), those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. However, we could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which we could be subject to are not material to the accompanying financial statements.
In January 2018, the FASB released guidance on the accounting for tax on the GILTI provision of the Tax Act. The GILTI provision imposes a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. The guidance indicates that either accounting for deferred taxes related to GILTI inclusions or treating any taxes on GILTI inclusions as a period cost are both acceptable methods subject to an accounting policy election. We have elected to treat any taxes on GILTI inclusions as a period cost.
A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. We have established a valuation allowance to offset deferred tax assets at January 31, 2021 and 2020 due to the uncertainty of realizing future tax benefits from our net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the years ended January 31, 2021 and 2020 was an increase of approximately $65.7 million and $5.4 million, respectively.
At January 31, 2021, we have federal, California and other state net operating loss carryforwards of approximately $1.9 billion, $522.1 million and $708.3 million, respectively, expiring beginning fiscal 2028, for federal and California purposes and fiscal 2021 for other states’ purposes.
At January 31, 2021, we have federal and state research credit carryforwards of approximately $63.1 million and $53.1 million, respectively, expiring beginning in fiscal 2029 for federal purposes. The state credits can be carried forward indefinitely.
Federal and state tax laws may impose substantial restrictions on the utilization of the net operating loss and credit carryforward attributes in the event of an ownership change as defined in Section 382 and Section 383 of the Internal Revenue Code. Accordingly, our ability to utilize these carryforwards may be limited as a result of such ownership changes. Such a limitation could result in the expiration of our net operating loss and credit carryforwards before they are utilized. We have performed an analysis through October 31, 2019 to determine whether an ownership change has occurred since inception. The analysis identified several historical ownership changes; however, the limitations did not result in a material restriction on the use of our carryforwards. In the event we experience any subsequent changes in ownership, the availability of our carryforwards in any taxable year could change.
For benefits to be recorded, a tax position must be more likely than not to be sustained upon examination. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon settlement.

The following table reflects the changes in the gross unrecognized tax benefits (in thousands):
Years Ended January 31,
202120202019
Balance as of beginning of year$24,400 $18,600 $11,700 
Tax positions taken in prior period:
     Gross increases — 600 — 
Tax positions taken in current period:
     Gross decreases — — (1,000)
     Gross increases(1)
3,400 5,200 7,900 
Balance as of end of year $27,800 $24,400 $18,600 
(1) Includes $7.4 million from the Hortonworks merger for fiscal year 2019.
As of January 31, 2021, the total amount of gross unrecognized tax benefits was $27.8 million, of which $2.2 million, if recognized, would impact our effective tax rate. We do not believe that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months.
We recognize interest and penalties related to income tax matters in the provision for income taxes. As of January 31, 2021, we had no accrued interest and penalties related to uncertain tax positions. We are subject to taxes in the United States and other foreign jurisdictions. In the normal course of business, we are subject to examination by various federal, state and local taxing authorities. We are not currently under audit by the Internal Revenue Service or any other tax authority. All tax years remain open to examination by major taxing jurisdictions in which we file returns.
In June 2019, the Ninth Circuit Court of Appeals issued a new opinion in the case of Altera Corp. v. Commissioner, which upheld Department of Treasury regulations which require related parties in an intercompany cost-sharing arrangement to share expenses related to stock-based compensation. In February 2020, Altera Corp. filed a petition to appeal the decision with the Supreme Court of the United States. In June 2020, the Supreme Court denied the petition. We have reviewed this decision and determined no adjustment is required to our consolidated financial statements as a result of this development.
v3.21.1
Related Party Transactions
 12 Months Ended
Jan. 31, 2021
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions Certain members of our board of directors currently serve on the board of directors or as an executive of certain companies that are our customers. The aggregate revenue we recognized from these customers was $8.5 million, $16.2 million and $21.2 million for the years ended January 31, 2021, 2020 and 2019, respectively. There was $2.2 million and $1.2 million in accounts receivable due from these customers as of January 31, 2021 and 2020, respectively.
v3.21.1
Segment Information
 12 Months Ended
Jan. 31, 2021
Segment Reporting [Abstract]  
Segment Information Segment Information
The results of the reportable segments are derived directly from our management reporting system and are based on our methods of internal reporting which are not necessarily in conformity with GAAP. Our management measures the performance of each segment based on several metrics, including contribution margin, as defined below. Our management does not use asset information to assess performance and make decisions regarding allocation of resources. Therefore, depreciation and amortization expense are not allocated among segments.
Contribution margin is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. Segment contribution margin includes segment revenue less the related cost of sales excluding certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, amortization of certain acquired intangible assets, impairment of real estate lease related assets, direct sales and marketing costs, research and development costs, corporate general and administrative costs, such as legal and accounting, interest income, interest expense, and other income and expense.
Financial information for each reportable segment was as follows (in thousands):
Years Ended January 31,
202120202019
Revenue:
Subscription $782,769 $667,826 $406,333 
Services 86,489 126,365 73,608 
Total revenue$869,258 $794,191 $479,941 

Years Ended January 31,
202120202019
Contribution margin:
Subscription $701,938 $577,899 $356,214 
Services 17,044 29,211 12,315 
Total segment contribution margin$718,982 $607,110 $368,529 

The reconciliation of segment financial information to our loss from operations is as follows (in thousands):
Years Ended January 31,
202120202019
Segment contribution margin$718,982 $607,110 $368,529 
Amortization of acquired intangible assets(78,306)(80,024)(9,129)
Stock-based compensation expense(188,935)(220,354)(117,365)
Impairment of real estate lease related assets(35,828)— — 
Corporate costs, such as research and development, corporate general and administrative and other(572,178)(646,486)(435,799)
Loss from operations$(156,265)$(339,754)$(193,764)
Sales outside of the United States represented approximately 40%, 38% and 34% of our total revenue for the years ended January 31, 2021, 2020 and 2019, respectively. No individual foreign country represented more than 10% of revenue in any period presented. All revenues from external customers are attributed to individual countries on an end-customer basis, based on domicile of the purchasing entity, if known, or the location of the customer’s headquarters if the specific purchasing entity within the customer is unknown.
As of January 31, 2021 and 2020, property and equipment, net located outside of the United States represented approximately 31% and 22% of total property and equipment, net, respectively.
v3.21.1
Net Loss Per Share
 12 Months Ended
Jan. 31, 2021
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share data):
Years Ended January 31,
202120202019
Numerator:
Net loss
$(162,734)$(336,582)$(192,649)
Denominator:
Weighted-average shares used in computing net loss, basic and diluted
302,522 280,772 159,816 
Net loss per share, basic and diluted
$(0.54)$(1.20)$(1.21)

The following outstanding shares of common stock equivalents were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):
As of
January 31,
202120202019
Stock options to purchase common stock 3,383 13,530 19,118 
Restricted stock awards 34,764 38,584 35,058 
Shares issuable pursuant to the ESPP787 969 724 
Total 38,934 53,083 54,900 
v3.21.1
Subsequent Events
 12 Months Ended
Jan. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events Subsequent EventIn February 2021, our Compensation Committee authorized the granting of RSUs representing an aggregate of 2,236,242 shares of common stock, and PRSUs representing an aggregate of 2,236,242 shares of common stock, to certain executive officers under the 2017 Plan. One twelfth of the RSUs shall vest and be settled on each quarterly anniversary date following the vesting commencement date. The PRSUs will vest based on Cloudera's achievement of certain performance goals during the performance period commencing on February 1, 2021 and ending on January 31, 2024. Upon achievement of performance goals, up to 1/6th of the PRSUs shall vest each half fiscal year subject to the executive’s continued service to Cloudera on the last day of the applicable half fiscal year. The number of PRSUs that will ultimately vest and be converted into shares of common stock will depend on Cloudera’s: (i) EBITDA excluding stock-based compensation; and (ii) Revenue.
v3.21.1
Summary of Business and Significant Accounting Policies (Policies)
 12 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]  
Basis of Consolidation The consolidated financial statements include the accounts of Cloudera, Inc. and its wholly owned subsidiaries which are located in various countries, including the United States, Australia, China, India, Germany, Ireland, The Netherlands, Singapore, Hungary and the United Kingdom. All intercompany balances and transactions have been eliminated upon consolidation. The financial statements are prepared in accordance with accounting principles generally accepted in the United States (GAAP).
Fiscal Year Our fiscal year ends on January 31. References to fiscal 2021, for example, refers to the fiscal year ending January 31, 2021.
Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant items subject to such estimates include the useful lives of property and equipment and intangible assets, allowance for credit losses, stock-based compensation expense, bonus attainment, self-insurance costs incurred, the fair value and useful lives of tangible and intangible assets acquired and liabilities assumed resulting from business combinations, the evaluation for impairment of goodwill, intangible assets and other long-lived assets including operating lease right-of-use assets, the estimated period of benefit for deferred contract costs, estimates related to our revenue recognition such as, the assessment of elements in a multi-element arrangement and the value assigned to each element, contingencies, and the incremental borrowing rate used in discounting our lease liabilities. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from these estimates.
Reclassifications
In the fourth quarter of fiscal 2021, we combined deferred revenue and other contract liabilities, both current and non-current, into contract liabilities current and non-current for all periods presented on our Consolidated Balance Sheets. All contract liabilities represent an obligation to transfer product offerings for which we have received consideration, or for which an amount of consideration is due from the customer (e.g., subscription arrangements where consideration is paid annually in advance).
Certain other immaterial prior year amounts have been reclassified to conform to current year presentation in the Balance Sheets, Consolidated Statements of Cash Flows and Notes to Consolidated Financial Statements.
Segments We operate as two operating segments – subscription and services. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is our chief executive officer, in deciding how to allocate resources and assess performance.
Foreign Currency Translation The functional currency of our foreign subsidiaries is generally the local currency. The gains and losses resulting from translating our foreign subsidiaries’ financial statements into U.S. dollars have been reported in accumulated other comprehensive income on the consolidated balance sheet. Assets and liabilities are translated at exchange rates in effect at the balance sheet date. Equity is translated at the historical rates from the original transaction period. Revenue and expenses are translated at average exchange rates in effect during the period. Foreign currency transaction gains and losses are included in other income (expense), net on the statement of operations.
Cash, Cash Equivalents and Restricted Cash Cash equivalents consist of short-term, highly liquid investments with original maturities of three months or less from the date of purchase. Restricted cash represents cash on deposit with financial institutions in support of letters of credit outstanding in favor of certain landlords for office space.
Marketable Securities We have investments in various marketable securities which are classified as available for sale. We determine the appropriate classification of marketable securities at the time of purchase and reevaluate such determination at each balance sheet date. The investments are adjusted for amortization of premiums and discounts to maturity and such amortization is included in interest income, net on the statement of operations. Changes in market value considered to be temporary are recorded as unrealized gains or losses in other comprehensive income (loss). Realized gains and losses and credit losses on available-for-sale securities are included in other income (expense), net on the statement of operations. The cost of securities sold is based on the specific-identification method.
Concentration of Credit Risk and Significant Customers Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, restricted cash and accounts receivable. Our cash is deposited with high credit quality financial institutions. At times, such deposits may be in excess of the Federal Depository Insurance Corporation insured limits. We have not experienced any losses on these deposits.
Accounts Receivable and Allowance for Credit Losses Our trade receivables are recorded at the invoice amount, net of an allowance for credit losses, which is not material. The allowance for credit losses reflects our best estimate of probable losses inherent in the receivable portfolio determined based on various factors including historical experience, credit quality of the customer, current economic conditions and management’s expectations of future economic conditions. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success.
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization of property and equipment is calculated using a straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not extend the life or improve the asset are expensed when incurred.
The estimated useful lives of our assets are as follows:
Computer software
2 years
Computer equipment
2-3 years
Furniture and office equipment
3 years
Leasehold improvements Shorter of remaining lease term or estimated useful life
We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the total of estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, would be assessed using discounted cash flows or other appropriate measures of fair value.
Leases
At the inception of a contract, we determine whether the contract is or contains a lease. All leases with a term greater than one year are recognized on the balance sheet as operating lease right-of-use (ROU) assets and lease liabilities. We have elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus will not have a lease liability or ROU asset recognized on the balance sheet.
ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our lease terms may include options to extend or terminate the lease, which we do not include in our minimum lease terms unless the options are reasonably certain to be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.
We have lease agreements with lease and non-lease components which we have elected to account for as a single lease component. On the lease commencement date, we establish assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense.
Additionally, we have unoccupied leased office space that we have either subleased, plan to sublease or plan to abandon. Any impairments to the ROU asset, leasehold improvements or other assets as a result of an unoccupied leased office space are recognized as an operating expense in the period the sublease is executed or in the case of a planned sublease or planned abandonment, upon the day of cease-use and determination that the lease related ROU asset, leasehold improvements or other assets are impaired. Any sublease payments received in excess of the straight-line rent payments for the sublease are recorded as an offset to operating expenses and recognized over the sublease life.
In the fourth quarter of fiscal year 2021, we recorded an impairment charge of $34.0 million for ROU assets and $1.8 million for related leasehold improvements and IT infrastructure, primarily related to certain office locations we determined will no longer be used. The impairment was determined by comparing the fair value of the impacted ROU asset, lease hold improvements and IT infrastructure to the carrying value of the assets as of the impairment measurement date, as required under Accounting Standards Codification (ASC) Topic 360, Property, Plant, and Equipment. There were no impairment charges recognized during the years ended January 31, 2020 and 2019. See Note 10 for additional discussion related to these impairment charges.
Goodwill and Intangible Assets
Goodwill represents the excess of the fair value of purchase consideration in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized, but rather tested for impairment at least annually or more often if circumstances indicate that the carrying value may not be recoverable.
Intangible assets are amortized over their useful lives. Each period we evaluate the estimated remaining useful life of our intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.
We evaluate the recoverability of our long-lived assets, including intangible assets, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, then the carrying amount of such assets is reduced to fair value.
Derivative Contracts We use derivative financial instruments as a part of our strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These derivative contracts consist of foreign currency forward contracts and are not designated as hedging instruments under the applicable accounting guidance. Accordingly, they are carried at fair value as either assets or liabilities on our consolidated balance sheets. The changes in the fair value are included in other income (expense), net within our consolidated statements of operations and are intended to offset the foreign currency gains or losses associated with the underlying monetary assets and liabilities.
Business Combinations We use our best estimates and assumptions to assign fair value to tangible and intangible assets acquired and liabilities assumed at the acquisition or merger date. Such estimates are inherently uncertain and subject to refinement. We continue to collect information and reevaluate these estimates and assumptions and record any adjustments to the preliminary estimates to goodwill provided that we are within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.
Capitalized Software Costs Capitalization of software development costs for products to be sold to third parties begins upon the establishment of technological feasibility and ceases when the product is available for general release. There is generally no significant passage of time between achievement of technological feasibility and the availability of our software for general release, and the majority of our software is open source. Therefore, we have not capitalized any software costs through January 31, 2021. All software development costs have been charged to research and development expense in the consolidated statements of operations as incurred.
Comprehensive Loss Comprehensive loss represents the net loss for the period plus the results of certain changes to stockholders’ equity that are not reflected in the consolidated statements of operations.
Revenue Recognition
We generate revenue from subscriptions and services. Subscription revenue relates to term (or time-based) subscription agreements for both open source and propriety software including support and, to a lesser extent, consumption-based revenue from our cloud offerings. Subscription arrangements are typically one to three years in length but may be up to seven years in limited cases. Arrangements with our customers typically do not include general right of returns. Services revenue relates to professional services for the implementation and use of our subscriptions, machine learning expertise and consultation, training and education services and related reimbursable travel costs.
We price our subscription offerings based on the number of servers in a cluster, or nodes, core or edge devices, data under management and/or the scope of support provided and/or on a consumption basis for our cloud-based solutions. Our consulting services are priced primarily on a time and materials basis, and to a lesser extent, a fixed fee basis, and training services are generally priced based on attendance.
We determine revenue recognition through the following steps, which are described in more detail below:
•Identification of the contract or contracts with a customer
•Identification of the performance obligation(s) in the contract
•Determination of the transaction price
•Allocation of the transaction price to the performance obligation(s) in the contract
•Recognition of revenue when, or as, a performance obligation is satisfied
Our agreements with customers often include multiple subscriptions and/or professional services elements, and these elements are sometimes included in separate contracts. We consider an entire customer arrangement to determine if separate contracts entered into at or near the same time should be considered combined for the purposes of revenue recognition. We work with partners in various capacities whereby we are typically responsible for providing the actual product or service as a principal.
At contract inception, we assess the subscription and services product offerings or bundle of product offerings in our contracts to identify performance obligations that are distinct. A performance obligation is distinct when it is separately identifiable from other items in a bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. To identify our performance obligations, we consider all of the product offerings promised in the contract. We have concluded that our contracts with customers do not contain warranties that give rise to a separate performance obligation.
The transaction price is the total amount of consideration we expect to be entitled to in exchange for the product offerings in a contract. Sales, value-added and other taxes we collect from customers concurrent with revenue-producing activities are excluded from revenue. In the instance where our contracts with customers contain variable consideration, we estimate variable consideration primarily using the expected value method.
Once we have determined the transaction price, the total transaction price is allocated to each performance obligation in a manner depicting the amount of consideration to which we expect to be entitled in exchange for transferring the product(s) or service(s) to the customer (allocation objective). If the allocation objective is met at contractual prices, no allocations are performed. Otherwise, we allocate the transaction price to each performance obligation identified in the contract on a relative stand-alone selling price basis.
In order to determine the stand-alone selling price, we conduct a periodic analysis that requires judgment and considers multiple factors that are reasonably available and maximizes the use of observable inputs that may vary over time depending upon the unique facts and circumstances related to each performance obligation. To have observable inputs, we require that a substantial majority of the stand-alone selling prices for a product offering fall within a pricing range. If a directly observable stand-alone selling price does not exist, we estimate a stand-alone selling price range by reviewing external and internal market factor categories, which may include pricing practices, historical discounting, industry practices, service groups and geographic considerations. There is also no hierarchy for how to estimate or otherwise determine the stand-alone selling price for product offerings that are not sold separately, however, we maximize the use of observable data. We believe that this analysis results in an estimate that approximates the price we would charge for the product offerings if they were sold separately.
The following describes the nature of our primary types of revenue and the revenue recognition policies and significant payment terms as they pertain to the types of transactions we enter into with our customers.
Subscription revenue
We sell subscriptions and services for an integrated suite of data analytics and management products. Our subscription offerings are based predominantly on open source software including Spark, Impala, Hive, HBase, Kafka, Hadoop, and more. The open source software is available from the Apache Software Foundation (ASF) or available through an Affero General Public License (AGPL). Certain subscriptions also include licenses of proprietary software that provide additional features and functionality not included in the open source software.
Subscription revenue relates to term (or time-based) subscriptions to our platform, which can include both open source and proprietary software and related support. Subscriptions include internet, email and phone support, bug fixes, and the right to receive unspecified software updates and upgrades released when and if available during the subscription term. Within our subscription arrangements, we account for the license to the proprietary software, if any, and support as two separate performance obligations. As the open source software is publicly available at no cost to the customer, we have determined that there is no value to be assigned to the open source software in our subscription arrangements. The proprietary software license represents a promise to provide a license to use functional intellectual property that is recognized at a point in time on the date access to the software is made available to the customer and the license period has begun. We have concluded the support is a stand-ready performance obligation that consists of a series of distinct days of service that are satisfied ratably over time as the services are provided. We use a time-based output method to measure progress because our efforts are expended evenly throughout the period given the nature of the promise is a stand-ready service. We recognize support revenue ratably, typically beginning on the start of the contractual term of the arrangement.
As part of our support offered under a subscription, we stand ready to help customers resolve technical issues related to the installed platform. The subscriptions are designed to assist throughout a customer’s lifecycle from development to proof-of-concept, to quality assurance and testing, to production and development. Our subscriptions are generally offered under renewable, fixed fee contracts where payments are typically due annually in advance and may have a term of one year or multiple years. The contracts generally do not contain refund provisions for fees earned related to services performed. Unearned subscription revenue is included in contract liabilities. On occasion, we may sell engineering services and/or a premium subscription agreement that provides a customer with development input and the opportunity to work more closely with our developers.
Services revenue
Services revenue is derived primarily from customer fees for consulting services engagements and education services. Our professional services are provided primarily on a time and materials basis and, to a lesser extent, a fixed fee basis, and education services are generally priced based on attendance. Time and material contracts are generally invoiced based upon hours incurred on a monthly basis and fixed fee contracts may be invoiced up-front or as milestones are achieved throughout the project. Services revenue is typically recognized over time as the services are rendered. Depending on the nature of the professional services engagement (e.g., time and materials basis, fixed fee basis, etc.), various measures of progress may be used to recognize revenue. These measures of progress include recognizing revenue in an amount equal to and at the time of invoicing, a measure of time incurred relative to
remaining hours expected to be delivered, or other similar measures. These measures depict our efforts to satisfy services contracts and therefore reflect the transfer of control for the services to a customer.
Contract Assets
Contract assets consist of the right to consideration in exchange for product offerings that we have transferred to a customer when that right is conditional on something other than the passage of time (e.g., performance prior to invoicing on fixed fee service arrangements with substantive acceptance terms). We record unbilled accounts receivable related to revenue recognized in excess of amounts invoiced as we have an unconditional right to invoice and receive payment in the future related to those fulfilled obligations. When we have unconditional rights to consideration, except for the passage of time, a receivable are recorded on the consolidated balance sheets. We do not typically include extended payment terms in our contracts with customers. As of January 31, 2021 and 2020, contract assets were $5.0 million and $4.6 million, respectively, which are included in prepaid expenses and other current assets.
Contract Liabilities
Contract liabilities represent an obligation to transfer product offerings for which we have received consideration, or for which an amount of consideration is due under our contracts with customers and is recognized as revenue as the revenue recognition criteria are met. Our contract balances are reported as net contract assets or liabilities on a contract-by-contract basis at the end of each reporting period.
Other Practical Expedients
We elected to apply a practical expedient related to significant financing components. The practical expedient states that the promised amount of consideration for the effects of a significant financing component is not adjusted if we expect, at contract inception, that the period between when we transfer a promised product offering to a customer and when the customer pays for that product offering will be one year or less.
Contract Costs
Contract costs, consisting primarily of sales commissions and payroll taxes, that are incremental to obtaining a subscription contract with a customer are capitalized and recorded as deferred costs. We expect to recover deferred contract costs over the period of benefit from the underlying contracts. The amortization period for recovery is consistent with the timing of transfer to the customer of services to which the capitalized costs relate. Contract costs that relate to an underlying transaction are expensed commensurate with the recognition of revenue as performance obligations are satisfied. Contract costs that are incurred in excess of those relating to an underlying transaction are not considered commensurate with recognition of revenue as performance obligations are satisfied and are amortized on a straight-line basis over the expected benefit period of five years. Commissions for services are treated as a separate class with a contract duration of less than a year and are expensed as incurred.
Cost of Revenue Cost of revenue for subscriptions and services is expensed as incurred. Cost of revenue for subscriptions primarily consists of personnel costs such as salaries, bonuses, travel costs, and benefits and stock-based compensation for employees providing technical support for our subscription customers, allocated shared costs (including rent and information technology) and amortization of certain acquired intangible assets from business combinations. Cost of revenue for services primarily consists of personnel costs including salaries, bonuses, benefits and stock-based compensation for employees and fees to subcontractors associated with service contracts, travel costs and allocated shared costs (including rent and information technology).
Research and Development Research and development costs are expensed as incurred and primarily consist of personnel costs including salaries, bonuses, travel costs, benefits and stock-based compensation for employees, contractor fees, allocated shared costs (including rent and information technology), supplies, and depreciation of equipment associated with the continued development of our platform prior to establishment of technological feasibility and the related maintenance of the existing technology.
Advertising Expenses Advertising is expensed as incurred.
Stock-Based Compensation
We recognize stock-based compensation expense for all stock-based payments over the requisite service period on a straight-line basis. Employee stock-based compensation cost is estimated at the grant date based on the fair value of the equity for financial reporting purposes. Stock-based compensation expense was recorded based on awards that were ultimately expected to vest, and such expense was reduced for forfeitures as they occurred.
We grant restricted stock units (RSUs) to our employees and members of our board of directors under our 2008 Equity Incentive Plan (2008 Plan) and our 2017 Equity Incentive Plan (2017 Plan). The fair value of RSUs is equal to our stock price at the close of market on the grant date. RSUs granted generally vest upon the satisfaction of a service-based vesting condition only, which is typically satisfied pro-rata over a period of three to four years.
We calculate the fair value of purchase rights granted under the Employee Stock Purchase Plan (ESPP) based on the Black-Scholes option-pricing model. The Black-Scholes model requires the use of various assumptions including expected term and expected stock price volatility. We estimate the expected term based on the offering period, which is six months. We estimate volatility based on historical realized volatility of our stock for the six months prior to issuance. The interest rate is derived from government bonds with a similar term. We have not declared nor do we expect to declare dividends. Therefore, there is no dividend impact on the valuation of ESPP purchase rights.
Income Taxes
We account for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when, in management’s estimate, it is more likely than not that the deferred tax asset will not be realized.
Any liability related to uncertain tax positions is recorded on the financial statements within other liabilities. Penalties and interest expense related to income taxes, including uncertain tax positions, are classified as a component of provision for income taxes, as necessary.
Commitments and Contingencies Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Recently Adopted and Issued Accounting Standards
Recently Adopted Accounting Standards
We adopted the following accounting standards in the first quarter of fiscal 2021:
•Accounting Standards Update (ASU) No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment;
•ASU No. 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which amends ASC 820, Fair Value Measurement; and
• ASU No. 2018-15, Intangibles-Goodwill and Other - Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force)
The adoption of the above listed accounting standards did not have a material impact on our consolidated financial statements for the year ended January 31, 2021.
In June 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13), which requires an entity to utilize a new impairment model known as the current expected credit loss model in place of the currently used incurred loss method. Under this update, on initial recognition and at each reporting period, an entity will be required to recognize an allowance that reflects the entity’s current estimate of credit losses expected to be incurred over the life of the financial instrument. For trade receivables, loans, and other financial instruments, an entity will be required to use a forward-looking expected loss model to recognize credit losses that are probable. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. We adopted ASU 2016-13 using the modified retrospective approach as of February 1, 2020. As a result of the adoption, we recorded a $0.8 million adjustment to our beginning accumulated deficit balance to reflect the cumulative effect of the accounting change. The impact of the adoption was not material to our consolidated financial statements as credit losses are not expected to be significant based on historical collection trends, the financial condition of payment partners and external market factors. We will continue to actively monitor the impact of the recent COVID-19 pandemic on expected credit losses.
Recently Issued Accounting Standards
In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs (ASU 2020-08) to provide further clarification and update the previously issued guidance in ASU 2017-08, Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20: Premium Amortization on Purchased Callable Debt Securities” (ASU 2017-08). ASU 2017-08 shortened the amortization period for certain callable debt securities purchased at a premium by requiring that the premium be amortized to the earliest call date. ASU 2020-08 requires that at each reporting period, to the extent that the amortized cost of an individual callable debt security exceeds the amount repayable by the issuer at the next call date, the excess premium shall be amortized to the next call date. ASU 2020-08 is effective for annual reporting periods and interim periods within those years, beginning after December 15, 2020 and to be applied prospectively. We will adopt this standard on February 1, 2021. We do not anticipate that ASU 2020-08 will have a material impact on our consolidated financial statements.
We continue to assess the potential impacts of the new standards, including the area described above, however, we do not know or cannot reasonably estimate quantitative information, beyond that discussed above, related to the impact of the new standard on the consolidated financial statements at this time.
Fair Value Measurement, Policy
We value our Level 1 assets using quoted prices in active markets for identical instruments. We value our Level 2 assets with the help of a third-party pricing service using quoted market prices for similar instruments, nonbinding market prices that are corroborated by observable market data, or pricing models such as discounted cash flow techniques. We use such pricing data as the primary input, to which we have not made any material adjustments during the periods presented, to make our determination and assessments as to the ultimate valuation of these assets.
Our foreign currency forward contract liabilities and assets are classified within Level 2 in the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, including currency spot and forward rates. The fair value of these contracts were not material as of January 31, 2021.
We have no Level 1 or 3 liabilities and no Level 3 assets measured on a recurring basis.
Assets Measured at Fair Value on a Nonrecurring Basis
Certain of our long-lived assets, including intangible assets, goodwill, and ROU assets are measured at fair value on a nonrecurring basis when there are indicators of impairment. In the fourth quarter of fiscal year 2021, we recorded impairment charges of $35.8 million on lease related ROU assets and other long-lived assets primarily related to certain office leases that we determined will no longer be used. The impairment was derived by comparing the fair value of the impacted assets to the carrying value of those assets as of the impairment measurement date, as required under ASC Topic 360 using Level 3 inputs.
v3.21.1
Summary of Business and Significant Accounting Policies (Tables)
 12 Months Ended
Jan. 31, 2021
Accounting Policies [Abstract]  
Schedule of Estimated Useful Lives of Company's Assets
The estimated useful lives of our assets are as follows:
Computer software
2 years
Computer equipment
2-3 years
Furniture and office equipment
3 years
Leasehold improvements Shorter of remaining lease term or estimated useful life
The cost and accumulated depreciation and amortization of property and equipment are as follows (in thousands):
As of January 31,
20212020
Computer equipment and software $24,974 $22,489 
Office furniture and equipment 13,352 12,672 
Leasehold improvements 24,719 24,236 
Property and equipment, gross 63,045 59,397 
Less: accumulated depreciation and amortization (44,980)(37,409)
Property and equipment, net $18,065 $21,988 
v3.21.1
Revenue from Contracts with Customers (Tables)
 12 Months Ended
Jan. 31, 2021
Revenue from Contract with Customer [Abstract]  
Contract with Customer, Asset and Liability
Significant changes in contract liabilities during the periods ended January 31, 2021 and 2020 are as follows (in thousands):
February 1, 2019$526,042 
Performance obligations satisfied during the period that were included in the contract liability balance at the beginning of the period(407,004)
Increases due to invoicing prior to satisfaction of performance obligations435,674 
January 31, 2020554,712 
Performance obligations satisfied during the period that were included in the contract liability balance at the beginning of the period(465,351)
Increases due to invoicing prior to satisfaction of performance obligations519,036 
January 31, 2021$608,397 
v3.21.1
Cash Equivalents and Marketable Securities (Tables)
 12 Months Ended
Jan. 31, 2021
Cash and Cash Equivalents [Abstract]  
Cash as Reported on the Condensed Consolidated Flows
The following are the fair values of our cash equivalents and marketable securities as of January 31, 2021 (in thousands):
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$186,127 $— $— $186,127 
Certificates of deposit4,000 — — 4,000 
Marketable securities:
U.S. agency obligations68,972 76 (4)69,044 
Asset-backed securities2,901 2 — 2,903 
Corporate notes and obligations210,321 1,215 (72)211,464 
Commercial paper48,212 19 (6)48,225 
Municipal securities40,031 213 (5)40,239 
Certificates of deposit60,749 53 — 60,802 
U.S. treasury securities38,291 34 — 38,325 
Total cash equivalents and marketable securities$659,604 $1,612 $(87)$661,129 

The following are the fair values of our cash equivalents and marketable securities as of January 31, 2020 (in thousands):
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$34,596 $— $— $34,596 
Marketable securities:
Asset-backed securities68,194 235 — 68,429 
Corporate notes and obligations199,226 891 — 200,117 
Commercial paper46,460 7 — 46,467 
Municipal securities20,865 65 — 20,930 
Certificates of deposit14,996 19 — 15,015 
U.S. treasury securities24,563 33 — 24,596 
Total cash equivalents and marketable securities$408,900 $1,250 $— $410,150 
Debt Securities, Available-for-sale
The contractual maturities of cash equivalents and marketable securities were as follows (in thousands):
January 31, 2021January 31, 2020
Amortized CostEstimated Fair ValueAmortized CostEstimated Fair Value
Due within one year$487,201 $487,848 $273,582 $274,058 
Due after one year through five years172,403 173,281 135,318 136,092 
Total cash equivalents and marketable securities$659,604 $661,129 $408,900 $410,150 
v3.21.1
Fair Value Measurement (Tables)
 12 Months Ended
Jan. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities According to the Fair Value Hierarchy, Measured at Fair Value The following table represents our financial assets according to the fair value hierarchy, measured at fair value as of January 31, 2021 (in thousands):
Level 1Level 2Total
Financial assets:
Money market funds $186,127 $— $186,127 
U.S. agency obligations — 69,044 69,044 
Asset-backed securities — 2,903 2,903 
Corporate notes and obligations — 211,464 211,464 
Commercial paper — 48,225 48,225 
Municipal securities — 40,239 40,239 
Certificates of deposit— 64,802 64,802 
U.S. treasury securities— 38,325 38,325 
Total financial assets$186,127 $475,002 $661,129 
The following table represents our financial assets according to the fair value hierarchy, measured at fair value as of January 31, 2020 (in thousands):
Level 1Level 2Total
Financial assets:
Money market funds $34,596 $— $34,596 
Asset-backed securities — 68,429 68,429 
Corporate notes and obligations — 200,117 200,117 
Commercial paper — 46,467 46,467 
Municipal securities — 20,930 20,930 
Certificates of deposit — 15,015 15,015 
U.S. treasury securities— 24,596 24,596 
Total financial assets$34,596 $375,554 $410,150 
v3.21.1
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Goodwill
Goodwill
The following table represents the changes to goodwill (in thousands):
Balance at January 31, 2019$586,456 
Other (1)
3,905 
Balance at January 31, 2020590,361 
Eventador acquisition8,930 
Balance at January 31, 2021$599,291 
(1) Other consists of certain purchase accounting adjustments related to our merger with Hortonworks in January 2019 and to an immaterial business combination.
Schedule of Intangible Assets
Intangible Assets
Intangible assets consisted of the following as of January 31, 2021 (in thousands):
Gross Fair
Value		Accumulated
Amortization		Net Book
Value		Weighted Average
Remaining Useful Life
(in years)
Developed technology$22,770 $(14,814)$7,956 3.3
Customer relationships and other acquired intangible assets671,947 (147,273)524,674 7.9
Unbilled contracts18,300 (18,300)— — 
Total$713,017 $(180,387)$532,630 7.8

Intangible assets consisted of the following as of January 31, 2020 (in thousands):
Gross Fair
Value		Accumulated
Amortization		Net Book
Value		Weighted Average
Remaining Useful Life
(in years)
Developed technology$17,570 $(11,321)$6,249 2.0
Customer relationships and other acquired intangible assets671,447 (80,847)590,600 8.9
Unbilled contracts18,300 (9,913)8,387 0.9
Total$707,317 $(102,081)$605,236 8.7
Finite-lived Intangible Assets Amortization Expense
The expected future amortization expense of these intangible assets as of January 31, 2021 is as follows (in thousands):
2022$70,239 
202367,887 
202467,376 
202567,286 
202666,875 
2027 and thereafter192,967 
Total amortization expense$532,630 
v3.21.1
Balance Sheet Components (Tables)
 12 Months Ended
Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cost and Accumulated Depreciation and Amortization of Property and Equipment
The estimated useful lives of our assets are as follows:
Computer software
2 years
Computer equipment
2-3 years
Furniture and office equipment
3 years
Leasehold improvements Shorter of remaining lease term or estimated useful life
The cost and accumulated depreciation and amortization of property and equipment are as follows (in thousands):
As of January 31,
20212020
Computer equipment and software $24,974 $22,489 
Office furniture and equipment 13,352 12,672 
Leasehold improvements 24,719 24,236 
Property and equipment, gross 63,045 59,397 
Less: accumulated depreciation and amortization (44,980)(37,409)
Property and equipment, net $18,065 $21,988 
Accrued Compensation and Other Accrued Liabilities
Accrued compensation consists of the following (in thousands):
As of January 31,
20212020
Accrued salaries, benefits and commissions$22,538 $27,067 
Accrued compensation-related taxes10,834 15,205 
Accrued bonuses 14,956 13,409 
Employee stock purchase plan withholdings2,634 2,732 
Other (1)
5,681 3,413 
Total accrued compensation $56,643 $61,826 
(1) Other consists primarily of amounts owed for severance-related benefits.
Other Accrued Liabilities
Other accrued liabilities consist of the following (in thousands):
As of January 31,
20212020
Accrued professional costs $3,790 $6,182 
Current portion of debt3,610 — 
Accrued taxes 5,596 5,164 
Accrued self-insurance costs 4,720 1,743 
Acquisition related holdback payments (1)
3,368 — 
Other (2)
9,112 9,208 
Total other accrued liabilities $30,196 $22,297 
(1) Business combination related payments held by Cloudera for indemnification purposes.
(2) Other relates primarily to amounts owed to third-party vendors that provide marketing, cloud-computing services and travel costs.
v3.21.1
Debt (Tables)
 12 Months Ended
Jan. 31, 2021
Debt Disclosure [Abstract]  
Schedule of Maturities of Long-term Debt
As of January 31, 2021, the expected future principal payments under the Term Loan are due as follows (in thousands):
2022$5,000 
20235,000 
20245,000 
20255,000 
20265,000 
2027 and thereafter475,000 
Total $500,000 
v3.21.1
Leases (Tables)
 12 Months Ended
Jan. 31, 2021
Leases [Abstract]  
Lease, Cost
Components of lease expense are summarized as follows (in thousands):
Years Ended January 31,
20212020
Operating lease cost $45,747 $45,640 
Short-term lease cost1,782 2,276 
Sublease income(14,730)(15,730)
Net lease cost (1)
$32,799 $32,186 
(1) Amount excludes ROU asset impairment charge of $35.8 million, as discussed below.
Lease Terms And Discount Rates
Lease term and discount rate information are summarized as follows:
As of January 31,
20212020
Weighted Average Remaining Lease Term (years)6.16.8
Weighted Average Discount Rate5.9 %6.0 %
Lessee, Operating Lease, Liability, Maturity
Maturities of lease liabilities as of January 31, 2021 are as follows (in thousands):
Minimum Lease Payments, Gross
2022$28,355 
202337,811 
202437,846 
202536,997 
202633,317 
2027 and thereafter55,243 
Total lease payments$229,569 
     Less imputed interest(40,699)
Present value of lease liabilities$188,870 
v3.21.1
Stock-Based Compensation (Tables)
 12 Months Ended
Jan. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity and related information under the Stock Plans:
Options Outstanding
Options
Outstanding (in thousands)		Weighted-
Average
Exercise
Price		Weighted-Average Remaining
Contractual
Term
(Years)		Aggregate
Intrinsic
Value
(in thousands)
Balance — January 31, 202013,530 $5.96 2.1$70,057 
Exercised
(9,197)3.89 —— 
Canceled
(950)14.22 —— 
Balance — January 31, 20213,383 $9.27 3.0$21,982 
Exercisable— January 31, 20213,382 $9.27 3.0$21,982 
Vested and Expected to Vest — January 31, 20213,383 $9.27 3.0$21,982 
Schedule of Weighted Average Assumptions in Calculating Option Fair Value
The fair value of each stock option grant was estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Year Ended January 31, 2019
Volatility 45.0%
Risk-free interest rate 2.5%
Expected term (in years) 5.0 years
Expected dividends —%
Schedule of Restricted Stock Activity
The following table summarizes RSU activity and related information under the Stock Plans:
RSUs Outstanding
Number of RSUs (in thousands)Weighted-Average Grant Date Fair Value Per Share
Balance —January 31, 202038,584 $10.85 
Granted 23,097 11.98 
Canceled (6,858)11.38 
Vested (20,059)10.14 
Balance —January 31, 202134,764 $11.91 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of each ESPP grant was estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Years Ended January 31,
202120202019
Volatility
66.8%31.9%38.8%
Risk-free interest rate
0.1%1.9%2.4%
Expected term (in years)
0.5 years0.5 years0.5 years
Expected dividends
—%—%—%
v3.21.1
Income Taxes (Tables)
 12 Months Ended
Jan. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Loss before Provision for Income Taxes
The domestic and foreign components of loss before provision for income taxes consisted of the following (in thousands):
Years Ended January 31,
202120202019
Domestic $(168,327)$(340,542)$(191,479)
Foreign 12,939 12,660 4,248 
Net loss before provision for income taxes $(155,388)$(327,882)$(187,231)
Schedule of Components of Provision for Income Tax
The components of provision for income taxes are as follows (in thousands):
Years Ended January 31,
202120202019
Current:
   Federal $— $— $— 
   State (16)(18)(106)
   Foreign (9,179)(8,766)(5,371)
Total (9,195)(8,784)(5,477)
Deferred:
   Federal 302 — — 
   State — — — 
   Foreign 1,547 84 59 
Total 1,849 84 59 
Total provision for income taxes $(7,346)$(8,700)$(5,418)
Reconciliation of Income Taxes at Statutory Federal Income Tax Rate to Provision for Income Taxes
A reconciliation of income taxes at the statutory federal income tax rate to the provision for income taxes included in the consolidated statements of operations is as follows (in thousands):
Years Ended January 31,
202120202019
U.S. federal statutory income tax $32,631 $68,856 $39,318 
Research tax credits 5,066 6,120 10,044 
Stock-based compensation 11,486 (6,395)(3,004)
Change in U.S. tax status of foreign entities (1)
1,646 (72,449)— 
Change in valuation allowance
(50,529)8,566 (42,450)
Foreign tax rate differential(5,507)(6,384)(4,945)
Legal expenses— — (4,000)
Global intangible low-taxed income— (3,668)— 
Non-deductible compensation(2,305)(1,150)— 
Other 166 (2,196)(381)
Provision for income taxes $(7,346)$(8,700)$(5,418)
(1) The change in U.S. tax status of foreign entities pertains to changes we made to our corporate entity operating structure, primarily as it pertains to transferring certain acquired intellectual property to the U.S. in fiscal 2020. As a result, certain foreign entities became disregarded for U.S. tax purposes. This change required the remeasurement of certain deferred taxes at tax rates different to those outside of the U.S. and the establishment of new deferred taxes for the disregarded entities, resulting in a one-time increase in our effective tax rate. Any tax provision impact was fully offset by a valuation allowance.
Schedule of Deferred Tax Assets and Liabilities
The deferred tax assets and liabilities were as follows (in thousands):
As of January 31,
20212020
Deferred tax assets:
   Accruals and reserves $13,079 $7,948 
   Deferred revenue 20,967 28,621 
   Net operating loss carryforwards 479,157 475,390 
   Research and development credits and other credits 84,278 75,168 
   Stock-based compensation 8,626 18,428 
 ROU assets/lease liability49,406 53,048 
   Capitalized research and development 52,532 10,351 
   Gross deferred tax assets 708,045 668,954 
Less valuation allowance (525,381)(459,649)
Total deferred tax assets, net of valuation allowance 182,664 209,305 
Deferred tax liabilities:
   Depreciation and amortization (124,773)(139,176)
ROU assets/lease liability(35,157)(48,085)
   Deferred costs(20,741)(21,609)
Gross deferred tax liabilities (180,671)(208,870)
Net deferred tax assets $1,993 $435 
Schedule of Changes in Gross Unrecognized Tax Benefits
The following table reflects the changes in the gross unrecognized tax benefits (in thousands):
Years Ended January 31,
202120202019
Balance as of beginning of year$24,400 $18,600 $11,700 
Tax positions taken in prior period:
     Gross increases — 600 — 
Tax positions taken in current period:
     Gross decreases — — (1,000)
     Gross increases(1)
3,400 5,200 7,900 
Balance as of end of year $27,800 $24,400 $18,600 
(1) Includes $7.4 million from the Hortonworks merger for fiscal year 2019.
v3.21.1
Segment Information (Tables)
 12 Months Ended
Jan. 31, 2021
Segment Reporting [Abstract]  
Schedule of Financial Information by Reportable Segment
Financial information for each reportable segment was as follows (in thousands):
Years Ended January 31,
202120202019
Revenue:
Subscription $782,769 $667,826 $406,333 
Services 86,489 126,365 73,608 
Total revenue$869,258 $794,191 $479,941 

Years Ended January 31,
202120202019
Contribution margin:
Subscription $701,938 $577,899 $356,214 
Services 17,044 29,211 12,315 
Total segment contribution margin$718,982 $607,110 $368,529 
Reconciliation of Segment Financial Information to Loss from Operations
The reconciliation of segment financial information to our loss from operations is as follows (in thousands):
Years Ended January 31,
202120202019
Segment contribution margin$718,982 $607,110 $368,529 
Amortization of acquired intangible assets(78,306)(80,024)(9,129)
Stock-based compensation expense(188,935)(220,354)(117,365)
Impairment of real estate lease related assets(35,828)— — 
Corporate costs, such as research and development, corporate general and administrative and other(572,178)(646,486)(435,799)
Loss from operations$(156,265)$(339,754)$(193,764)
v3.21.1
Net Loss Per Share (Tables)
 12 Months Ended
Jan. 31, 2021
Earnings Per Share [Abstract]  
Schedule of the Calculation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share data):
Years Ended January 31,
202120202019
Numerator:
Net loss
$(162,734)$(336,582)$(192,649)
Denominator:
Weighted-average shares used in computing net loss, basic and diluted
302,522 280,772 159,816 
Net loss per share, basic and diluted
$(0.54)$(1.20)$(1.21)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding shares of common stock equivalents were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been anti-dilutive (in thousands):
As of
January 31,
202120202019
Stock options to purchase common stock 3,383 13,530 19,118 
Restricted stock awards 34,764 38,584 35,058 
Shares issuable pursuant to the ESPP787 969 724 
Total 38,934 53,083 54,900 
v3.21.1
Summary of Business and Significant Accounting Policies - Narrative (Details)
 12 Months Ended
Jan. 31, 2021
USD ($)
customer
segment
Jan. 31, 2020
USD ($)
customer
Jan. 31, 2019
USD ($)
Jan. 31, 2018
USD ($)
Concentration Risk [Line Items]        
Operating segments | segment 2      
Number of customers with 10% accounts receivable balance | customer 1 0    
Allowance for doubtful accounts $ 2,700,000 $ 800,000    
Impairment of property and equipment 0 0 $ 0  
Goodwill impairment 0 0 0  
Impairment of intangible assets 0 0 0  
Contract assets 5,000,000.0 4,600,000    
Contract costs 84,200,000 90,000,000.0    
Capitalized contract cost, amortization 66,700,000 47,600,000 30,600,000  
Advertising expense 11,500,000 15,400,000 6,900,000  
Stockholders' equity attributable to parent (1,127,930,000) (1,438,369,000) (1,562,069,000) $ (428,174,000)
Accumulated Deficit        
Concentration Risk [Line Items]        
Stockholders' equity attributable to parent $ 1,649,355,000 1,485,824,000 $ 1,149,242,000 $ 956,593,000
Cumulative Effect, Period of Adoption, Adjustment        
Concentration Risk [Line Items]        
Stockholders' equity attributable to parent   797,000    
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit        
Concentration Risk [Line Items]        
Stockholders' equity attributable to parent   $ 797,000    
Restricted Stock Units        
Concentration Risk [Line Items]        
Award vesting period (in years) 4 years      
Minimum        
Concentration Risk [Line Items]        
Subscription period 1 year      
Minimum | Restricted Stock Units        
Concentration Risk [Line Items]        
Award vesting period (in years) 3 years      
Minimum | 2017 Equity Incentive Plan | Restricted Stock Units        
Concentration Risk [Line Items]        
Award vesting period (in years) 3 years      
Maximum        
Concentration Risk [Line Items]        
Subscription period 3 years      
Subscription period, limited cases 7 years      
Maximum | 2017 Equity Incentive Plan | Restricted Stock Units        
Concentration Risk [Line Items]        
Award vesting period (in years) 4 years      
v3.21.1
Summary of Business and Significant Accounting Policies - Schedule of Estimated Useful Lives of Company's Assets (Details)
 12 Months Ended
Jan. 31, 2021
Computer software  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 2 years
Computer equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 2 years
Computer equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
Furniture and office equipment  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
v3.21.1
Revenue from Contracts with Customers - Significant Changes in Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Contract Liability [Roll Forward]    
Contract liabilities, balance beginning of period $ 554,712 $ 526,042
Performance obligations satisfied during the period that were included in the contract liability balance at the beginning of the period (465,351) (407,004)
Increases due to invoicing prior to satisfaction of performance obligations 519,036 435,674
Contract liabilities, balance end of period $ 608,397 $ 554,712
v3.21.1
Revenue from Contracts with Customers - Performance Obligations (Details)
$ in Millions
Jan. 31, 2021
USD ($)
Revenue from Contract with Customer [Abstract]  
Revenue, remaining performance obligation, amount $ 953.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-02-01  
Revenue from Contract with Customer [Abstract]  
Revenue, remaining performance obligation, amount $ 662.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01  
Revenue from Contract with Customer [Abstract]  
Revenue, remaining performance obligation, amount $ 291.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, remaining performance obligation, expected timing of satisfaction, period
v3.21.1
Business Combination - Narrative (Details) - USD ($)
$ in Thousands
Oct. 08, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Business Acquisition [Line Items]        
Goodwill   $ 599,291 $ 590,361 $ 586,456
Eventador Labs, Inc        
Business Acquisition [Line Items]        
Business acquisition, percentage of voting interests acquired 100.00%      
Payments to acquire businesses, gross $ 18,000      
Business combination, contingent consideration, liability $ 3,500      
Contingent consideration, liability, payment term 3 years      
Business acquisition, consideration paid $ 14,500      
Goodwill 8,900      
Finite-lived intangibles $ 5,700      
Eventador Labs, Inc | Minimum        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, estimated remaining useful life 4 years      
Eventador Labs, Inc | Maximum        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, estimated remaining useful life 5 years      
v3.21.1
Cash Equivalents and Marketable Securities - Schedule of Fair Value of Cash and Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Marketable securities:    
Unrealized Gains $ 1,612 $ 1,250
Unrealized Losses (87) 0
Total, Amortized Cost 659,604 408,900
Total, Estimated Fair Value 661,129 410,150
U.S. agency obligations    
Marketable securities:    
Amortized Cost 68,972  
Unrealized Gains 76  
Unrealized Losses (4)  
Estimated Fair Value 69,044  
Asset-backed securities    
Marketable securities:    
Amortized Cost 2,901 68,194
Unrealized Gains 2 235
Unrealized Losses 0 0
Estimated Fair Value 2,903 68,429
Corporate notes and obligations    
Marketable securities:    
Amortized Cost 210,321 199,226
Unrealized Gains 1,215 891
Unrealized Losses (72) 0
Estimated Fair Value 211,464 200,117
Commercial paper    
Marketable securities:    
Amortized Cost 48,212 46,460
Unrealized Gains 19 7
Unrealized Losses (6) 0
Estimated Fair Value 48,225 46,467
Municipal securities    
Marketable securities:    
Amortized Cost 40,031 20,865
Unrealized Gains 213 65
Unrealized Losses (5) 0
Estimated Fair Value 40,239 20,930
Certificates of deposit    
Marketable securities:    
Amortized Cost 60,749 14,996
Unrealized Gains 53 19
Unrealized Losses 0 0
Estimated Fair Value 60,802 15,015
U.S. treasury securities    
Marketable securities:    
Amortized Cost 38,291 24,563
Unrealized Gains 34 33
Unrealized Losses 0 0
Estimated Fair Value 38,325 24,596
Money market funds    
Cash equivalents:    
Amortized Cost 186,127 34,596
Cash equivalents 186,127 $ 34,596
Certificates of deposit    
Cash equivalents:    
Amortized Cost 4,000  
Cash equivalents $ 4,000  
v3.21.1
Cash Equivalents and Marketable Securities - Narrative (Details)
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Minimum    
Cash and Cash Equivalents [Line Items]    
Marketable securities term 1 year 1 year
Maximum    
Cash and Cash Equivalents [Line Items]    
Marketable securities term 3 years 3 years
v3.21.1
Cash Equivalents and Marketable Securities - Summary of Contractual Maturities of Investments (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Amortized Cost    
Due within one year $ 487,201 $ 273,582
Due after one year through five years 172,403 135,318
Total cash equivalents and marketable securities 659,604 408,900
Estimated Fair Value    
Due within one year 487,848 274,058
Due after one year through five years 173,281 136,092
Total cash equivalents and marketable securities $ 661,129 $ 410,150
v3.21.1
Fair Value Measurement - Schedule of Financial Assets and Liabilities According to the Fair Value Hierarchy, Measured at Fair Value (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 186,127 $ 34,596
U.S. agency obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 69,044  
Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,903 68,429
Corporate notes and obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 211,464 200,117
Municipal securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 40,239 20,930
Certificates of deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 60,802 15,015
U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 38,325 24,596
Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total financial assets 661,129 410,150
Fair Value, Measurements, Recurring | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 186,127 34,596
Fair Value, Measurements, Recurring | U.S. agency obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 69,044  
Fair Value, Measurements, Recurring | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,903 68,429
Fair Value, Measurements, Recurring | Corporate notes and obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 211,464 200,117
Fair Value, Measurements, Recurring | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 48,225 46,467
Fair Value, Measurements, Recurring | Municipal securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 40,239 20,930
Fair Value, Measurements, Recurring | Certificates of deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 64,802 15,015
Fair Value, Measurements, Recurring | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 38,325 24,596
Fair Value, Measurements, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total financial assets 186,127 34,596
Fair Value, Measurements, Recurring | Level 1 | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 186,127 34,596
Fair Value, Measurements, Recurring | Level 1 | U.S. agency obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0  
Fair Value, Measurements, Recurring | Level 1 | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Corporate notes and obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Municipal securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Certificates of deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 1 | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Fair Value, Measurements, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total financial assets 475,002 375,554
Fair Value, Measurements, Recurring | Level 2 | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Fair Value, Measurements, Recurring | Level 2 | U.S. agency obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 69,044  
Fair Value, Measurements, Recurring | Level 2 | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,903 68,429
Fair Value, Measurements, Recurring | Level 2 | Corporate notes and obligations    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 211,464 200,117
Fair Value, Measurements, Recurring | Level 2 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 48,225 46,467
Fair Value, Measurements, Recurring | Level 2 | Municipal securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 40,239 20,930
Fair Value, Measurements, Recurring | Level 2 | Certificates of deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 64,802 15,015
Fair Value, Measurements, Recurring | Level 2 | U.S. treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities $ 38,325 $ 24,596
v3.21.1
Fair Value Measurement - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jan. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Fair Value Disclosures [Abstract]        
Impairment of real estate lease related assets $ 35,800,000 $ 35,828,000 $ 0 $ 0
v3.21.1
Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Goodwill [Roll Forward]    
Beginning balance $ 590,361 $ 586,456
Other   3,905
Eventador acquisition 8,930  
Ending balance $ 599,291 $ 590,361
v3.21.1
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Gross Fair Value $ 713,017 $ 707,317
Accumulated Amortization (180,387) (102,081)
Net Book Value $ 532,630 $ 605,236
Weighted Average Remaining Useful Life (in years) 7 years 9 months 18 days 8 years 8 months 12 days
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Fair Value $ 22,770 $ 17,570
Accumulated Amortization (14,814) (11,321)
Net Book Value $ 7,956 $ 6,249
Weighted Average Remaining Useful Life (in years) 3 years 3 months 18 days 2 years
Customer relationships and other acquired intangible assets    
Finite-Lived Intangible Assets [Line Items]    
Gross Fair Value $ 671,947 $ 671,447
Accumulated Amortization (147,273) (80,847)
Net Book Value $ 524,674 $ 590,600
Weighted Average Remaining Useful Life (in years) 7 years 10 months 24 days 8 years 10 months 24 days
Unbilled contracts    
Finite-Lived Intangible Assets [Line Items]    
Gross Fair Value $ 18,300 $ 18,300
Accumulated Amortization (18,300) (9,913)
Net Book Value $ 0 $ 8,387
Weighted Average Remaining Useful Life (in years)   10 months 24 days
v3.21.1
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense of intangible assets $ 78.3 $ 80.0 $ 9.1
v3.21.1
Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]    
2022 $ 70,239  
2023 67,887  
2024 67,376  
2025 67,286  
2026 66,875  
2027 and thereafter 192,967  
Net Book Value $ 532,630 $ 605,236
v3.21.1
Derivative Contracts (Details)
$ in Millions
 12 Months Ended
Jan. 31, 2021
USD ($)
Other Income (Expense)  
Derivative [Line Items]  
Derivative instruments not designated as hedging instruments, loss $ 1.0
Foreign currency derivative contracts | Not Designated as Hedging Instrument  
Derivative [Line Items]  
Derivative, notional amount $ 18.7
v3.21.1
Balance Sheet Components - Schedule of Cost and Accumulated Depreciation and Amortization of Property and Equipment (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 63,045 $ 59,397
Less: accumulated depreciation and amortization (44,980) (37,409)
Property and equipment, net 18,065 21,988
Computer equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 24,974 22,489
Furniture and office equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 13,352 12,672
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 24,719 $ 24,236
v3.21.1
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Depreciation $ 11.1 $ 12.1 $ 8.3
v3.21.1
Balance Sheet Components - Accrued Compensation and Other Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Accrued Compensation    
Accrued salaries, benefits and commissions $ 22,538 $ 27,067
Accrued compensation-related taxes 10,834 15,205
Accrued bonuses 14,956 13,409
Employee stock purchase plan withholdings 2,634 2,732
Other 5,681 3,413
Total accrued compensation 56,643 61,826
Other Accrued Liabilities    
Accrued professional costs 3,790 6,182
Long-term debt, current maturities 3,610 0
Accrued taxes 5,596 5,164
Accrued self-insurance costs 4,720 1,743
Acquisition related holdback payments 3,368 0
Other 9,112 9,208
Other accrued liabilities $ 30,196 $ 22,297
v3.21.1
Debt - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 22, 2020
Jan. 31, 2021
Jan. 31, 2020
Debt Instrument [Line Items]      
Long-term debt, current maturities   $ 3,610,000 $ 0
Long-term debt, excluding current maturities   $ 487,089,000 $ 0
Secured Debt | Term Loan B      
Debt Instrument [Line Items]      
Long-term debt, term 7 years    
Debt instrument, face amount $ 500,000,000.0    
Debt instrument, annual principal payment, percentage 1.00%    
Debt instrument, interest rate, effective percentage   3.25%  
Interest expense, debt   $ 1,700,000  
Debt instrument, unamortized discount (premium) and debt issuance costs, net $ 9,500,000    
Long-term debt   490,700,000  
Long-term debt, current maturities   3,600,000  
Long-term debt, excluding current maturities   $ 487,100,000  
Secured Debt | Term Loan B | Minimum      
Debt Instrument [Line Items]      
Debt instrument, basis spread on variable rate 3.25%    
Secured Debt | Term Loan B | Eurodollar      
Debt Instrument [Line Items]      
Debt instrument, basis spread on variable rate 2.50%    
Secured Debt | Term Loan B | Base Rate      
Debt Instrument [Line Items]      
Debt instrument, basis spread on variable rate 1.50%    
v3.21.1
Debt - Expected Future Principal Payments (Details)
$ in Thousands
Jan. 31, 2021
USD ($)
Debt Disclosure [Abstract]  
2022 $ 5,000
2023 5,000
2024 5,000
2025 5,000
2026 5,000
2027 and thereafter 475,000
Total $ 500,000
v3.21.1
Leases - Components of Lease Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Leases [Abstract]    
Operating lease cost $ 45,747 $ 45,640
Short-term lease cost 1,782 2,276
Sublease income (14,730) (15,730)
Net lease cost $ 32,799 $ 32,186
v3.21.1
Leases - Lease Term and Discount Rate (Details)
Jan. 31, 2021
Jan. 31, 2020
Leases [Abstract]    
Weighted Average Remaining Lease Term (years) 6 years 1 month 6 days 6 years 9 months 18 days
Weighted Average Discount Rate 5.90% 6.00%
v3.21.1
Leases - Maturities (Details)
$ in Thousands
Jan. 31, 2021
USD ($)
Leases [Abstract]  
2022 $ 28,355
2023 37,811
2024 37,846
2025 36,997
2026 33,317
2027 and thereafter 55,243
Total lease payments 229,569
Less imputed interest (40,699)
Present value of lease liabilities $ 188,870
v3.21.1
Leases - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jan. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Leases [Abstract]        
Impairment of real estate lease related assets $ 35,800,000 $ 35,828,000 $ 0 $ 0
Sublease, rental proceeds, next two years $ 14,500,000 14,500,000    
Operating lease, impairment loss   34,000,000.0    
Impairment of long-lived assets to be disposed of   $ 1,800,000    
v3.21.1
Commitments and Contingencies - Narrative (Details)
$ in Millions
Oct. 16, 2020
plantiff
Sep. 22, 2020
directorOrOfficer
defendant
Jan. 31, 2021
USD ($)
Jan. 31, 2020
USD ($)
Oct. 16, 2019
derivativeAction
directorOrOfficer
Sep. 05, 2019
directorOrOfficer
Sep. 03, 2019
directorOrOfficer
Jul. 30, 2019
directorOrOfficer
Jun. 07, 2019
directorOrOfficer
Loss Contingencies [Line Items]                  
Letters of credit | $     $ 19.4 $ 19.9          
Loss contingency, number of derivative actions | derivativeAction         3        
In re Cloudera, Inc. Securities Litigation                  
Loss Contingencies [Line Items]                  
Loss contingency, number of defendants | defendant   4              
Loss contingency, number of directors or officers   14              
Loss Contingency, Number of Plaintiffs | plantiff 2                
Lazard v. Cloudera, Inc                  
Loss Contingencies [Line Items]                  
Loss contingency, number of directors or officers                 13
Lee, et al. v. Cole, et al.                  
Loss Contingencies [Line Items]                  
Loss contingency, number of directors or officers               11  
Slattery v. Reilly, et al.                  
Loss Contingencies [Line Items]                  
Loss contingency, number of directors or officers           13      
Frentzel v. Bearden, et al.                  
Loss Contingencies [Line Items]                  
Loss contingency, number of directors or officers         13        
Chen v. Reilly, et al.                  
Loss Contingencies [Line Items]                  
Loss contingency, number of directors or officers             13    
v3.21.1
Common Stock Repurchases - Narrative (Details) - USD ($)
$ / shares in Units, shares in Millions
 12 Months Ended
Jan. 31, 2021
Dec. 02, 2020
Mar. 03, 2020
Accelerated Share Repurchases [Line Items]      
Repurchases of common stock $ 340,066,000    
Stock repurchase program, remaining authorized repurchase amount 259,900,000    
Share Repurchase Program, March 3, 2020      
Accelerated Share Repurchases [Line Items]      
Stock repurchase program, authorized amount     $ 100,000,000
Repurchases of common stock $ 26,000,000.0    
Treasury stock, shares, acquired (in shares) 3.9    
Treasury stock acquired, average cost per share (in usd per share) $ 6.56    
Share Repurchase Program, December 2, 2020      
Accelerated Share Repurchases [Line Items]      
Stock repurchase program, authorized amount   $ 500,000,000  
Repurchases of common stock $ 314,100,000    
Treasury stock, shares, acquired (in shares) 26.1    
Treasury stock acquired, average cost per share (in usd per share) $ 12.05    
v3.21.1
Stock-Based Compensation - Narrative (Details)
 1 Months Ended 12 Months Ended
Feb. 28, 2021
Feb. 01, 2021
shares
Jan. 31, 2019
USD ($)
Mar. 31, 2017
shares
Jan. 31, 2021
USD ($)
plan
hour
$ / shares
shares
Jan. 31, 2020
USD ($)
$ / shares
Jan. 31, 2019
USD ($)
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of plans | plan         2    
Stock-based compensation         $ 6,600,000 $ 20,900,000  
Award expiration period (in years)         10 years    
Intrinsic value of exercised options         $ 75,800,000 26,200,000 $ 31,200,000
Grant date fair value         400,000 $ 1,600,000 $ 27,900,000
Weighted average grant date value of employee options (in dollars per share) | $ / shares             $ 4.58
Share-based compensation arrangement by share-based payment award, value withheld for future purchases         $ 2,600,000    
Employee Stock Option | After one year              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         1 year    
Award vesting (as a percent)         25.00%    
Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         4 years    
Granted (in dollars per share) | $ / shares         $ 11.98 $ 8.96 $ 12.08
Fair value of RSUs vested during period         $ 216,100,000 $ 218,300,000 $ 128,700,000
Unamortized stock based compensation expense RSUs         $ 381,900,000    
Average remaining vesting period (in years)         2 years 3 months 18 days    
Restricted Stock Units | Subsequent Event              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting (as a percent) 8.33%            
Restricted Stock Units | After one year              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         1 year    
Award vesting (as a percent)         25.00%    
Restricted Stock Units | Remaining three years              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         3 years    
Minimum | Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         3 years    
Minimum | Employee Stock Option | Remaining three years              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         2 years    
Minimum | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         3 years    
Maximum | Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         4 years    
Maximum | Employee Stock Option | Remaining three years              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         3 years    
Equity Incentive Plan 2017              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Reserved for issuance under plans (in shares) | shares       30,000,000 13,720,801    
Restriction on increase to shares outstanding (as a percent)       5.00%      
Equity Incentive Plan 2017 | Subsequent Event              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Increase in shares reserved for grant (in shares) | shares   14,561,036          
Equity Incentive Plan 2017 | Minimum | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         3 years    
Equity Incentive Plan 2017 | Maximum | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)         4 years    
Employee Stock Purchase Plan 2017              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Reserved for issuance under plans (in shares) | shares         3,000,000    
Restriction on increase to shares outstanding (as a percent)         1.00%    
Share purchase period (in years)         6 months    
Minimum weekly hours worked for plan eligibility | hour         20    
Minimum months worked for plan eligibility         5 months    
Maximum ownership interest for plan participation (as a percent)         5.00%    
Purchase price (as a percent)         85.00%    
Maximum stock value purchased         $ 25,000    
Maximum shares purchased (in shares) | shares         2,500    
Years for increasing shares included in plan         10 years    
Shares available for grant (in shares) | shares         4,344,158    
Employee Stock Purchase Plan 2017 | Subsequent Event              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Reserved for issuance under plans (in shares) | shares   2,912,207          
Employee Stock Purchase Plan 2017 | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Maximum payroll deduction (as a percent)         1.00%    
Employee Stock Purchase Plan 2017 | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Maximum payroll deduction (as a percent)         15.00%    
Hortonworks, Inc              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Fair value of stock awards assumed     $ 63,500,000        
Share based compensation, weighted average period     1 year 6 months        
Stock-based compensation             $ 13,100,000
v3.21.1
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Options Outstanding    
Balance at the beginning of the period (in shares) 13,530,000  
Exercised (in shares) (9,197,000)  
Canceled (in shares) (950,000)  
Balance at the end of the period (in shares) 3,383,000 13,530,000
Exercisable (in shares) 3,382,000  
Vested and expected to vest (in shares) 3,383,000  
Weighted- Average Exercise Price    
Balance at the beginning of the period (in dollars per share) $ 5.96  
Exercised (in dollars per share) 3.89  
Canceled (in dollars per share) 14.22  
Balance at the end of the period (in dollars per share) 9.27 $ 5.96
Exercisable (in dollars per share) 9.27  
Vested and expected to vest (in dollars per share) $ 9.27  
Weighted-Average Remaining Contractual Term (Years)    
Balance 3 years 2 years 1 month 6 days
Exercisable— January 31, 2021 3 years  
Vested and Expected to Vest — January 31, 2021 3 years  
Aggregate Intrinsic Value (in thousands)    
Balance $ 21,982 $ 70,057
Exercisable— January 31, 2021 21,982  
Vested and Expected to Vest — January 31, 2021 $ 21,982  
v3.21.1
Stock-Based Compensation - Schedule of Weighted Average Assumptions in Calculating Option Fair Value (Details) - Employee Stock Option
 12 Months Ended
Jan. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Volatility (as a percent) 45.00%
Risk-free interest rate (as a percent) 2.50%
Expected term (in years) 5 years
Expected dividends (as a percent) 0.00%
v3.21.1
Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) - Restricted Stock Units - $ / shares
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Number of Restricted Stock Units      
Number of Restricted Stock Units Outstanding Beginning of Period (in shares) 38,584,000    
Granted (in shares) 23,097,000    
Canceled (in shares) (6,858,000)    
Vested (in shares) (20,059,000)    
Number of Restricted Stock Units Outstanding End of Period (in shares) 34,764,000 38,584,000  
Weighted- Average Grant Date Fair Value Per Share      
Weighted- Average Grant Date Fair Value Per Share Beginning of Period (in dollars per share) $ 10.85    
Granted (in dollars per share) 11.98 $ 8.96 $ 12.08
Canceled (in dollars per share) 11.38    
Vested (in dollars per share) 10.14    
Weighted- Average Grant Date Fair Value Per Share End of Period (in dollars per share) $ 11.91 $ 10.85  
v3.21.1
Stock-Based Compensation - Fair Value of ESPP Using Black-Scholes (Details) - Shares issuable pursuant to the ESPP
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility (as a percent) 66.80% 31.90% 38.80%
Risk-free interest rate (as a percent) 0.10% 1.90% 2.40%
Expected term (in years) 6 months 6 months 6 months
Expected dividends (as a percent) 0.00% 0.00% 0.00%
v3.21.1
Income Taxes - Schedule of Domestic and Foreign Components of Loss before Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Income Tax Disclosure [Abstract]      
Domestic $ (168,327) $ (340,542) $ (191,479)
Foreign 12,939 12,660 4,248
Loss before provision for income taxes $ (155,388) $ (327,882) $ (187,231)
v3.21.1
Income Taxes - Schedule of Components of Provision for Income Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Current:      
Federal $ 0 $ 0 $ 0
State (16) (18) (106)
Foreign (9,179) (8,766) (5,371)
Total (9,195) (8,784) (5,477)
Deferred:      
Federal 302 0 0
State 0 0 0
Foreign 1,547 84 59
Total 1,849 84 59
Total provision for income taxes $ (7,346) $ (8,700) $ (5,418)
v3.21.1
Income Taxes - Reconciliation of Income Taxes at Statutory Federal Income Tax Rate to Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Income Tax Disclosure [Abstract]      
U.S. federal statutory income tax $ 32,631 $ 68,856 $ 39,318
Research tax credits 5,066 6,120 10,044
Stock-based compensation 11,486 (6,395) (3,004)
Change in U.S. tax status of foreign entities 1,646 (72,449) 0
Change in valuation allowance (50,529) 8,566 (42,450)
Foreign tax rate differential (5,507) (6,384) (4,945)
Legal expenses 0 0 (4,000)
Global intangible low-taxed income 0 (3,668) 0
Non-deductible compensation (2,305) (1,150) 0
Other 166 (2,196) (381)
Total provision for income taxes $ (7,346) $ (8,700) $ (5,418)
v3.21.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2021
Jan. 31, 2020
Deferred tax assets:    
Accruals and reserves $ 13,079 $ 7,948
Deferred revenue 20,967 28,621
Net operating loss carryforwards 479,157 475,390
Research and development credits and other credits 84,278 75,168
Stock-based compensation 8,626 18,428
ROU assets/lease liability 49,406 53,048
Capitalized research and development 52,532 10,351
Gross deferred tax assets 708,045 668,954
Less valuation allowance (525,381) (459,649)
Total deferred tax assets, net of valuation allowance 182,664 209,305
Deferred tax liabilities:    
Depreciation and amortization (124,773) (139,176)
ROU assets/lease liability (35,157) (48,085)
Deferred costs (20,741) (21,609)
Gross deferred tax liabilities (180,671) (208,870)
Net deferred tax assets $ 1,993 $ 435
v3.21.1
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2018
Operating Loss Carryforwards [Line Items]        
Increase in valuation allowance $ 65,700,000 $ 5,400,000    
Unrecognized tax benefits 27,800,000 $ 24,400,000 $ 18,600,000 $ 11,700,000
Unrecognized tax benefits that would impact effective tax rate 2,200,000      
Income tax penalties and interest accrued 0      
Federal        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards 1,900,000,000      
Research and development credits and other credits 63,100,000      
State        
Operating Loss Carryforwards [Line Items]        
Research and development credits and other credits 53,100,000      
State | California        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards 522,100,000      
State | Other State Board        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards $ 708,300,000      
v3.21.1
Income Taxes - Schedule of Changes in Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance as of beginning of year $ 24,400 $ 18,600 $ 11,700
Tax positions taken in prior period, gross increases 0 600 0
Tax positions taken in current period, gross decreases 0 0 (1,000)
Tax positions taken in current period, gross increases 3,400 5,200 7,900
Balance as of end of year $ 27,800 $ 24,400 18,600
Hortonworks, Inc      
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Tax positions taken in current period, gross increases     $ 7,400
v3.21.1
Related Party Transactions - Narrative (Details) - Affiliated Entity - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Related Party Transaction [Line Items]      
Revenue from related party $ 8.5 $ 16.2 $ 21.2
Accounts receivable related party $ 2.2 $ 1.2  
v3.21.1
Segment Information - Schedule of Financial Information by Reportable Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax $ 869,258 $ 794,191 $ 479,941
Contribution margin 718,982 607,110 368,529
Subscription      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 782,769 667,826 406,333
Contribution margin 701,938 577,899 356,214
Services      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Excluding Assessed Tax 86,489 126,365 73,608
Contribution margin $ 17,044 $ 29,211 $ 12,315
v3.21.1
Segment Information - Reconciliation of Segment Financial Information to Loss from Operations (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jan. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Segment Reporting Information [Line Items]        
Contribution margin   $ 718,982,000 $ 607,110,000 $ 368,529,000
Amortization of acquired intangible assets   (78,300,000) (80,000,000.0) (9,100,000)
Impairment of real estate lease related assets $ (35,800,000) (35,828,000) 0 0
Corporate costs, such as research and development, corporate general and administrative and other [1],[2]   (836,335,000) (901,443,000) (537,591,000)
Loss from operations   (156,265,000) (339,754,000) (193,764,000)
Operating Segments        
Segment Reporting Information [Line Items]        
Contribution margin   718,982,000 607,110,000 368,529,000
Corporate, Non-Segment        
Segment Reporting Information [Line Items]        
Amortization of acquired intangible assets   (78,306,000) (80,024,000) (9,129,000)
Stock-based compensation expense   (188,935,000) (220,354,000) (117,365,000)
Impairment of real estate lease related assets   (35,828,000) 0 0
Corporate costs, such as research and development, corporate general and administrative and other   $ (572,178,000) $ (646,486,000) $ (435,799,000)
[1] Amounts include amortization of acquired intangible assets as follows (in thousands):
Years Ended January 31,
202120202019
Cost of revenue - subscription$11,880 $11,213 $3,251 
Sales and marketing 66,426 68,811 5,878 
[2] Amounts include stock-based compensation expense as follows (in thousands):
Years Ended January 31,
202120202019
Cost of revenue – subscription $15,123 $16,599 $9,959 
Cost of revenue – services 11,909 17,609 11,492 
Research and development 72,087 75,554 41,430 
Sales and marketing 55,173 63,360 27,918 
General and administrative 34,643 47,232 26,566 
v3.21.1
Segment Information - Narrative (Details) - Non-US - Geographic Concentration
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Revenue from Contract with Customer Benchmark      
Concentration Risk [Line Items]      
Concentration risk (more than) (as a percent) 40.00% 38.00% 34.00%
Property, Plant and Equipment      
Concentration Risk [Line Items]      
Concentration risk (more than) (as a percent) 31.00% 22.00%  
v3.21.1
Net Loss Per Share - Schedule of the Calculation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Numerator:      
Net loss $ (162,734) $ (336,582) $ (192,649)
Denominator:      
Weighted-average shares used in computing net loss per share, basic and diluted (in shares) 302,522 280,772 159,816
Net loss per share, basic and diluted (in dollars per share) $ (0.54) $ (1.20) $ (1.21)
v3.21.1
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares) 38,934 53,083 54,900
Stock options to purchase common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares) 3,383 13,530 19,118
Restricted stock awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares) 34,764 38,584 35,058
Shares issuable pursuant to the ESPP      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares) 787 969 724
v3.21.1
Subsequent Events (Details) - Subsequent Event
Feb. 28, 2021
shares
Restricted Stock Units  
Subsequent Event [Line Items]  
Stock reserved for grant (in shares) 2,236,242
Award vesting (as a percent) 8.33%
Performance Shares  
Subsequent Event [Line Items]  
Stock reserved for grant (in shares) 2,236,242
Award vesting (as a percent) 16.67%
v3.21.1
Label Element Value
Restricted Cash, Noncurrent us-gaap_RestrictedCashNoncurrent $ 3,352,000
Restricted Cash, Noncurrent us-gaap_RestrictedCashNoncurrent 3,367,000
Restricted Cash, Noncurrent us-gaap_RestrictedCashNoncurrent $ 3,352,000